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DEVELOPMENT OF NOVEL INKS AND APPROACHES FOR PRINTING 




Tissue engineering is a multidisciplinary field that investigates and develops new methods 
to repair, regenerate and replace damaged tissues and organs, or to develop biomaterial 
platforms as in vitro models. Tissue engineering approaches require the fabrication of 
scaffolds using biomaterials or fabrication of living tissues using cells. As the demands of 
customized, implantable tissue/organs are increasing and becoming more urgent, 
conventional scaffold fabrication approaches are difficult to meet the requirements, 
especially for complex large-scale tissue fabrication. In this regard, three-dimensional (3D) 
printing attracted more interest over the past decades due to its unrivaled ability to fabricate 
highly customized tissues or scaffolds from patients’ medical images using computer aided 
design (CAD), as well as its flexibility, cost-effectiveness, and high efficiency. And more 
recently, 3D bioprinting can fabricate cellular constructs using a “bioink”, an aqueous 
composite formulation that contained live cells as a mandatory component, which is a big 
step towards functional organ fabrications.  
However, to fully realize the potential of 3D (bio)printing in tissue engineering, 
there are still a lot of barriers before implantable artificial organs, including but not limited 
to vascularization of fabricated tissue/organs, multicellular biofabrication, limited 
functional biomaterial, and dynamic maintenance/remodeling. To address some of these 
problems, this dissertation aims to develop novel inks and approaches for printing tissue 
and organs. Firstly, a novel bioprinting approach is developed to create user-defined 
 
 
complex perfusable channels within cell-laden hydrogels, which uses commercially 
available bioprinters, hydrogels, and open-source software. The printing process is cell-
friendly, and the channels could be further endothelialized to make the cell-laden hydrogel 
a vascularized tissue. Secondly, novel bioinks from UV-responsive norbornene-
functionalized carboxymethyl cellulose macromers are developed. The cost-effectiveness, 
tunability, degradability, and cytocompatibility make this bioink platform a good addition 
to the current available bioink library. Thirdly, considering the demands of fabricating hard 
degradable scaffolds for bone tissue engineering, a polyester-based ink platform with 
tunable bioactivity is developed. Functionalized 3D printed scaffolds show a significant 
impact that enhanced the osteogenesis of human stem cells. Finally, the impact of the 
architectures of the 3D printed scaffolds on stem cell differentiation is investigated, which 
demonstrated enhanced osteogenesis of human stem cells on scaffolds with wavy 
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1.1 3D Printing Technologies for Tissue Engineering and Regenerative Medicine 
Tissue engineering is a multidisciplinary field currently focused on two major areas: (i) 
developing new methods to repair, regenerate and replace damaged tissues and organs, and 
(ii) creating in vitro tissue models to better understand tissue development, disease 
development and progression, and to develop and screen drugs [1-6]. Despite recent 
advances in tissue engineering, there is a continuous lack of tissues and organs for 
transplantation and a shortage of tissue models for drug discovery and testing [7]. 
Conventional techniques, such as porogen-leaching, injection molding, and 
electrospinning, are generally recognized as the bottleneck due to limited control over 
scaffold architecture, composition, pore shape, size, and distribution [8-10]. 3D bioprinting 
is an emerging field enabling fabrication of scaffolds, devices, and tissue models with high 
complexity [9-12]. 3D printing allows the construction of tissues or scaffolds from 
commonly used medical images (such as X-ray, magnetic resonance imaging (MRI), and 
computerized tomography (CT) scan) using computer aided design (CAD). Custom and 
patient-specific design, on-demand fabrication, high structural complexity, low-cost, and 
high-efficiency are some of the major advantages of 3D printing, making it very attractive 
for medicine [13, 14]. 
Tissue engineering scaffolds are three-dimensional porous structures providing an 
infrastructure for cells to infiltrate, adhere, proliferate, and enabling new tissue formation 
for functional integration [1]. Scaffolds are generally required to display bioactivity to 
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instruct cellular behavior, such as adhesion, proliferation, migration, and differentiation [3]. 
In addition, control over composition, stiffness, degradation, and structural architecture are 
required as cells are responsive to their microenvironment [3, 15]. In vitro tissue models 
require the ability to fabricate cell only or cell-biomaterial platforms that mimic cellular 
organization (spatial distribution of multiple cell lines) and microenvironment (stiffness, 
structural topography, and biochemical cues) in relatively high resolution (25-100 μm) [2, 
4, 5, 16, 17]. 3D printing has the potential to fabricate these complex platforms.  
 
1.2 3D Bioprinting and 3D Printing of Biomaterials 
Tissue engineering approaches require the fabrication of scaffolds using biomaterials or 
fabrication of living tissues using cells. 3D printed scaffolds can be utilized directly, 
allowing native cells to infiltrate and regenerate the tissue when implanted, or after seeded 
with cells. The printable material is referred as a “biomaterial ink.” Currently available 3D 
printing technologies allow a wide range of biomaterials to be printed using diverse 
biomaterial ink formulations [13]. 3D printing technologies for biomaterial printing are 
classified under four main groups in this work: extrusion-based, droplet-based, powder-
based, and vat photopolymerization-based printing. Extrusion-based printing technologies 
include fused filament fabrication (FFF) or known as under trademark fused deposition 
modeling (FDM), and direct ink writing (DIW). FDM utilizes synthetic thermoplastics and 
their composites with ceramics or metals [18]. For FDM, the form of the ink material is a 
filament, and it is extruded at elevated temperatures (140-250 ℃) in a melt state. Direct 
ink writing (DIW) allows extrusion of polymer melts, high viscosity solutions, hydrogels, 
and colloidal suspensions [19]. Inkjet printing is a droplet-based technology, and the 
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processing principle is the deposition of polymeric solutions and colloidal suspensions, 
with relatively low viscosities (< 10 cP (mPa.s)) at relatively high shear rates (105-106 s-1) 
in the form of droplets (~50 m in diameter) [20-23]. Selective laser sintering (SLS) 
utilizes metals, ceramics, polymers, and composites in powder form (10-150 μm in 
diameter). In this technique, a directed laser beam locally melts either directly the powder 
or a polymeric binder onto the bed surface [24]. Layers of fresh powder are continuously 
supplied after each layer is created. Binder jetting is another powder-based printing 
technology, which jets binder polymers to selectively bond powder materials into 3D green 
bodies, followed by infiltration or sintering to achieve final products [25]. The vat 
photopolymerization approaches require a viscous photocurable polymer solution or a 
prepolymer, which is exposed to a directed light (such as UV or laser) to spatially crosslink 
the solution [26].  
 Three dimensional bioprinting is a technology that allows the fabrication of living 
tissues/constructs from living cells with or without a carrier material [9-11, 27, 28]. The 
material that is printed is referred to as a “bioink”, which can be defined as an ink 
formulation that allows the printing of living cells. 3D bioprinting process should be 
relatively mild and cell-friendly as it is required to allow cell printing [29]. This 
requirement limits the number of 3D printing techniques that are suitable for bioprinting. 
DIW allows the printing of cell suspensions and/or aggregates with or without a hydrogel 
carrier. Inkjet printing is another technology for cell printing. As compared to DIW, inkjet 
bioprinters are not readily available, yet there are commercially available inkjet print heads 
that are suitable for bioprinting [30, 31]. Vat photopolymerization-based 3D printing 
technologies, such as SLA, digital light processing (DLP), and continuous digital light 
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processing (cDLP), have emerged in printing live cells as long as a cell-laden prepolymer 
formulation is used and the photocuring takes place in a mild, cell-friendly condition, 
which are the two major issues for vat photopolymerization-based bioprinting [32-34]. In 
addition to these technologies, laser induced forward transfer (LIFT) is also shown to be 
suitable for bioprinting [35-40]. In this technique, an ink solution is coated onto a glass 
slide and coated with a laser absorption layer (metal or metal oxide). The laser is directed 
to the laser absorption layer with an ablation spot size between 40 to 100 μm in diameter 
[35, 37], creating a local pressure to eject the ink layer to the substrate.  
 
 
Figure 1.1 Different Types of 3D Printing Technologies.  
Source: Adapted with permission [41], copyright 2016, American Chemical Society. 
 
Among 3D printing techniques, extrusion-based printing is the most commonly 
used technology due to ease of use, availability, and low cost. In this regard, this 
dissertation is focusing on developing novel inks for extrusion-based biomaterial printing 




1.3 Currently Available Bioinks and Biomaterial inks 
Noticeably, many of the biomaterial ink formulations are not suitable for cell printing. For 
instance, polycaprolactone (PCL) and poly(lactic acid) (PLA) are the most widely used 
biomaterials in 3D printing. However, they could only be printed at elevated temperatures 
in the form of a polymer melt, or when dissolved in organic solvents as a polymer solution. 
Therefore, they are not considered as bioinks, as both approaches are not suitable for live 
cell printing [42, 43].  
Currently, cell-laden hydrogels (also known as scaffold-based bioinks) and cell-
only bioinks (also known as scaffold-free bioinks) are the two major types of bioinks 
(Figure 1.2) [44-46]. Cell-laden hydrogels are particularly attractive due to their tunable 
properties and their ability to recapitulate the cellular microenvironment [47]. Cell-laden 
hydrogel bioink formulations utilize natural hydrogels such as agarose, alginate, chitosan, 
collagen, gelatin, fibrin, and hyaluronic acid, as well as synthetic hydrogels such as 
poly(ethylene glycol) (PEG) and its derivatives. Natural hydrogels offer inherent 
bioactivity (except for agarose and alginate) and display a structural resemblance to ECM. 
For instance, fibrin and collagen hydrogels with inherent filamentous structure display 
strain-stiffening property, mimicking the non-linear elastic behavior of the soft tissues in 
our body [48, 49]. Synthetic hydrogels permit but don’t promote cellular function, yet there 
are many ways to tether bioactive cues into synthetic hydrogels [15]. When compared to 
natural hydrogels, synthetic hydrogels generally offer tunable mechanical properties. Many 
natural polymers (such as gelatin and hyaluronic acid) have functionalizable backbone side 
chains enabling them to be functionalized with chemical moieties to induce crosslinking 
(chemical- and/or photo-crosslinking) or additional bioactivity [50]. Blends of synthetic 
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and natural polymers have been used to develop mechanically tunable hydrogels with user-
defined bioactivity. In addition, the mechanical properties and/or bioactivity can also be 
tuned by incorporating small amounts of nanoparticles into bioink formulation [51]. 
Derived from native tissues by removing the cells from the tissue while retaining the native 
extracellular matrix (ECM) ingredients, decellularized extracellular matrix (dECM)-based 
bioink formulations are an emerging field due to their inherent bioactivity and ease of 
formulation into a printable bioink [52, 53]. The compositions of dECM-based bioinks are 
more comprehensive than the others, which contains a tissue-specific complex composition 
of structural and functional ECM components of native tissue, such as collagen, 
glycosaminoglycans (GAGs), and growth factors [53-56]. This unique advantage makes 
dECM-based bioinks a good candidate for 3D bioprinting of tissue constructs [52, 57-59].  
On the other hand, cell-only bioinks, including cell suspension, cell spheroids, and 
cell strands, are a viable option to create scaffold-free biological constructs [60, 61]. 
Modified inkjet printers have long been used to print cells into cellular assemblies. For 
instance, endothelial cells were printed from cell suspension (1 × 105 cells/ml) in growth 
media [62]. Bioprinting of scaffold-free constructs utilizes cell aggregates in the form of 
mono- or multi-cellular spheroids as a bioink [23, 63-65]. The bioink formulation 
undergoes fully biological self-assembly without or in the presence of a temporary support 
layer [63]. This technique relies on tissue liquidity and fusion, which allows cells to self-
assemble and fuse due to cell-cell interactions [66-68]. Recently, due to the advantage of 
freeform bioprinting, pelleted cells were directly printed within a support bath in 3D 





Figure 1.2 Examples of currently available bioinks: (A) an explanted embryonic chick 
heart bioprinted with cell-laden hydrogel: (i) darkfield image, and (ii) a confocal 
microscope image of the chick heart stained for fibronectin (green), nuclei (blue), and F-
actin (red). (scale bar: 1 mm).; (B) A heart bioprinted with personalized cell-laden dECM-
based hydrogel: (i) visualizing the left and right ventricles of the heart by injecting red and 
blue dyes, and (ii) a confocal image that visualized the bioprinted cardiomyocytes (pink), 
and endothelial cells (orange) (scale bar: 1 mm); (C) bioprinting of cell-only bioink (cell 
spheroids): (i) to (iii): bioprinted cellular patterns with cell spheroids, and (iv) stacking cell 
spheroids without supports.  
Source: Adapted under the terms of the CC-BY 4.0 license [70]. Copyright 2015, the Authors. Published by 
American Association for the Advancement of Science. 
Adapted under the terms of the CC-BY 4.0 license [59]. Copyright 2019, the Authors. Published by John 
Wiley and Sons 
Adapted under the terms of the CC-BY-NC 4.0 license [71]. Copyright 2020, the Authors. Published by 
American Association for the Advancement of Science. 
 
As to biomaterial inks, thermoplastic biomaterial inks, hydrogel inks, ceramic-
based inks, and composite inks are currently available [41]. Thermoplastic biomaterials are 
the most commonly used in 3D printing of scaffolds, especially for desktop 3D printers, as 
a result of the ease to be processed, cost-effectiveness, biocompatibility, degradability, and 
mechanics. Thermoplastics could be engineered to be printed by extrusion-based (FDM 
and DIW), powder-based (SLS), and vat polymerization-based (SLA, DLP, cDLP) 3D 
printing techniques. Each of these techniques requires different material properties. For 
FDM and DIW at high temperatures, thermoplastics must render a rapid solid-to-melt 
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transition to secure melt formation pre-extrusion and solidification post-extrusion, whereas 
shear thinning properties of the melt are also required [18]. Specifically, for FDM, the 
value of the elastic modulus/melt viscosity should be lower than 5×105 s-1 to prevent 
filament buckling. In this regard, many thermoplastic biomaterials are available for high 
temperature FDM/DIW printing, including but not limited to PLA [72], PCL [73], 
polyether ether ketone (PEEK) [74], poly(butylene terephthalate) (PBT) [75], acrylonitrile 
butadiene styrene (ABS) [76], thermoplastic poly(urethane) (TPU) [77], and thermoplastic 
composite materials [78]. Unlike FDM, in which the ink must be in a filament form, DIW 
can print polymer solutions and hydrogels at low temperatures. The printable polymer 
solutions are typically comprised of volatile organic solvents, such as dichloromethane, 
chloroform, and tetrahydrofuran, which permits rapid dissipation within seconds after 
extrusion. Moreover, thermoplastic particles could be suitable for SLS, which requires the 
particle diameters in the range of 10-150 μm to permit good flowability and print resolution, 
and the melt viscosity should be low as well [79]. Finally, thermoplastics, such as 
poly(D,L-lactide) (PDLLA) [80] and poly(propylene fumarate) (PPF) [81], are also 
available for vat polymerization-based 3D printing (SLA, DLP, cDLP).  
Hydrogel inks are also great candidates for DIW, which has been mentioned in the 
bioink sections. Besides, sacrificial hydrogels such as Pluronic F-127 (Pluronic) render 
excellent printability and fidelity, which is commonly used as support material during 
bioprinting processes [82]. Ceramic-based inks are also of great significance, especially 
for bone tissue engineering, due to their high stiffness and bioactivities [83]. 
Hydroxyapatite and tricalcium phosphates (TCP) are two major ceramic biomaterials used 
in bone tissue engineering. Due to the high melting point and processing difficulty, it is 
9 
 
convenient to mix ceramic biomaterials with polymers to formulate composite inks for 3D 
printing [84, 85]. Ceramic inks are also available to be printed in bulk forms by binder 
jetting of SLS [25, 86, 87]. As pure materials often fail to render all the desired properties, 
single material inks have been formulated with other materials as composite inks to 
enhance ink properties, which includes polymer-based, hydrogel-based, and ceramic-based 
composites. For instance, PCL could be supplemented by hydroxyapatite/TCP and growth 
factors to enhance the osteogenic function of the 3D printed scaffolds [88]. 
  
 
Figure 1.3 Distinction between a bioink (left side) in which cells work as a mandatory 
component, and a biomaterial ink (right side), where a biomaterial is used to print a scaffold 
for cell seeding. 




1.4 Complex 3D Bioprinting 
3D bioprinting technology already enabled the fabrication of small-scale tissues [5, 90, 91], 
and in the short-term, these bioprinted tissues could potentially address the lack of 
functional in vitro tissue/disease models for personalized medicine and drug screening. In 
the long-term, bioprinting show strong potential to address the shortage of implantable 
organs [27, 92]. To achieve these short- and long-term goals, it is crucial to capture the 
architectural, structural, mechanical, and biochemical complexity of the native tissue. This 
requires the bioprinting process to evolve from small-scale, low-resolution, single or dual 
cell and biomaterial printing to human-scale, high-resolution, multi-cellular, and multi-
biomaterial printing [93-95]. For complex 3D bioprinting, two aspects of complexities of 
the printed tissue/organ constructs are usually considered to resemble in vivo conditions, 
including the tissue architecture and the physical (stiffness) and biochemical (cells and 
bioactive cues) complexity. Due to layer-by-layer fabrication, 3D printing of complex 
architectures such as tubular and spiral as well as hollow structures (such as embedded 
channels for vascularization) is limited. Native tissues are multicellular that compromise 
many cell types, which requires the ability to formulate and bioprint multiple cell types 
while maintaining their phenotype or derive them into site-specific lineages. To resemble 
the physical and biological complexity, it is crucial to place a multitude of bioinks within 
a 3D space allowing precise distribution of multiple cell types and ECM mimetic materials. 
Besides, the fabrication of vascular networks that are embedded within the bioprinted 
tissues is one of the key issues to achieve large-scale bioprinting, as vasculature is crucial 
for nutrient supply and waste removal to overcome mass transfer limitations [96, 97]. 
Recent advances in bioprinting technology and bioink development enabled to 
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overcome some of the abovementioned issues (Figure 1.4). For instance, 3D printing 
integrated with gel-casting is one of the widely used strategies for the fabrication of channel 
structures embedded within 3D cell-laden hydrogels (Figure 1.4A) [98-104]. This 
approach includes mold fabrication, 3D printing of sacrificial structures within the mold, 
hydrogel precursor solution casting into the mold followed by hydrogel crosslinking, and 
finally removal of the sacrificial structure. Another convenient approach is 3D bioprinting 
with support materials (Figure 1.4B) [52, 58, 82, 105-107]. By printing a sturdy framework 
of support material along with the bioinks, the bioprinted tissue construct becomes self-
supportive. The support ink can be a sacrificial hydrogel such as Pluronic, which can be 
removed after printing, or a thermoplastic (such as PCL and polyurethane (PU)) that can 
remain to provide mechanical stability for the bioprinted structure both in vitro and in vivo. 
In addition, the approach is efficient for bioprinting straight tubular structures in 
macroscale (Figure 1.4C). In the unit-stacking approach, cell-laden hydrogels are 
bioprinted as cylinders or spheroids, which serve as the building units that can be stacked 
into the desired shape or a construct [63, 108-112]. Moreover, Coaxial bioprinting is 
suitable for the continuous fabrication of tubular structures (Figure 1.4D). The key feature 
of coaxial bioprinting is the 2-layered nozzle, which enables co-extrusion of two different 
bioink formulations in a core-shell manner [113-115]. Due to the ease of direct bioprinting 
of tubular channels, researchers formulated endothelial cell-laden bioactive bioinks to 
fabricate thick, vascularized, functional tissues [57, 116-120], and recent studies showed 
coaxial bioprinting of heterogenous and hallow filaments enabling fabrication of complex 
tissue constructs [121-124]. However, the layer-by-layer printing process significantly 
limits the achievable complexity of the microstructures and 3D anisotropy as well as the 
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ability to print tissue mimetic soft hydrogels (elastic modulus below 100 kPa) or cells alone. 
Freeform extrusion-based bioprinting overcomes these issues by eliminating the need for 
layer-by-layer fabrication and enabling omnidirectional freeform fabrication (Figure 1.4E) 
[125]. In this approach, DIW is performed within a support bath which physically supports 
the printed structure. The ink is extruded out of a needle-like nozzle that moves through a 
support bath, deposited within the bath, and held in place [59, 70, 126-130]. Last but not 
least, vat photopolymerization-based printing approaches have gained recent attention due 
to their ability to create support-free complex structures and omnidirectional printing 
(Figure 1.4F). In particular, light-assisted printing using projection, including DLP and 
cDLP, attracted more interest due to enhanced print speed as compared to SLA [34, 131-
144]. 
Although the abovementioned techniques enable complex bioprinting, yet there is 
still more to accomplish to achieve the fabrication of fully functional, human-scale, and 





Figure 1.4 The evolution of complex bioprinting: (A) 3D printing integrated with gel-
casting; (B) 3D bioprinting with support materials; (C) unit-stacking approach; (D) coaxial 
bioprinting; (E) Freeform bioprinting; (F) Light-assisted bioprinting. 
 
1.5 Objectives 
In this dissertation, two main objectives are presented: 
Objective 1. To develop a novel bioprinting approach to create complex microchannels 
within cell-laden hydrogels.  
Objective 2. To extend the range of available inks for tissue engineering applications 
Objective 2.1. To develop novel bioinks from UV-responsive norbornene-
functionalized carboxymethyl cellulose macromers 
Objective 2.2. To develop a functional polyester-based ink platform with the 




1.6 Dissertation Organization 
In Chapter 2, a novel 3D bioprinting approach is developed to create complex 
microchannels within cell-laden hydrogels, which utilized photocurable and sacrificial 
hydrogels.  
In Chapter 3, novel bioinks from UV-responsive norbornene-functionalized 
carboxymethyl cellulose macromers are developed, where the formulation, rheological 
properties, printability/printing process, and cell viability were investigated.  
In Chapter 4, a novel functional polyester-based ink platform with tunable 
bioactivity was developed, which has promising rheological, mechanical, and biological 
properties towards 3D printing of tissue engineering scaffolds for bone regeneration. 
In Chapter 5, 3D porous scaffolds with wavy or linear patterns were printed to 
investigate the effect of wavy scaffold architecture on hMSC osteogenesis.  
In Chapter 6, the summary and conclusion of this dissertation are provided. And 




3D BIOPRINTING OF COMPLEX CHANNELS  
WITHIN CELL-LADEN HYDROGELS 
This chapter has been adapted from the publication: 
S. Ji, E. Almeida, M. Guvendiren, 3D bioprinting of complex channels within cell-laden 
hydrogels, Acta Biomaterialia 95 (2019) 214-224. 
 
2.1 Introduction 
The advances in additive manufacturing technologies enabled the fabrication of complex 
3D scaffolds and medical devices [9, 27, 28, 82, 145, 146]. To fabricate clinically relevant 
and human scale tissue and organs, development of 3D constructs with vascular networks 
is one of the major bottlenecks [96, 147-149]. Thus, there is a growing demand for novel 
approaches to create perfusable microchannels, with tunable sizes and shapes, within 3D 
printed hydrogel constructs. Hydrogel constructs with embedded microchannels are also 
essential for the development of organ-on-a-chip systems for fundamental studies relating 
to tissue development and disease, and potentially be useful for drug testing [150].  
Besides 3D bioprinting, various approaches were reported to fabricate tubular 
vessels, porous constructs, and microchannels to develop vascular structures, including 
solvent-casting and particulate leaching [151-153], gas foaming [154], fiber bonding [155], 
phase separation [156, 157], electrospinning [158], and self-assembly/healing [159, 160]. 
Yet, 3D bioprinting offers many advantages, including precise control of channel size, 
shape, and location (within the construct), and the ability to print multiple-materials 
including cells and cell-laden hydrogels [161].  
In the past decade, several strategies have been developed to create microchannels 
within 3D printed constructs. Gel-casting on a 3D printed sacrificial network is a 
convenient approach to fabricate embedded microchannels within hydrogels [98-101]. In 
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this approach, a curable hydrogel solution is casted on a 3D printed sacrificial template 
(scaffold) using a mold. A wide range of sacrificial ink materials have been used (agarose, 
gelatin, Pluronic, and sugar-based materials) to create microchannels [98-100, 162-164]. 
For example, Miller et al. reported the use 3D printed sugar-based inks to fabricate 
sacrificial (e.g., water-soluble) templates (scaffolds), and were able to fabricate a range of 
constructs (from curable hydrogels) with embedded channels, with diameters ranged from 
150 μm to 800 μm [98]. Lewis group utilized a similar approach to fabricate hydrogels 
with vascularized, perfusable channels (using water-soluble Pluronic) that can support 
encapsulated cell growth for more than 6 weeks [100]. Although this approach is shown to 
be efficient in creating embedded microchannels within hydrogels, it is almost impossible 
to place channels at a user-defined height unless multiple printing (of sacrificial material) 
and gel-casting steps are introduced. Another approach is free-form bioprinting, which 
refers to direct printing of a material (e.g., hydrogel ink) into a support bath (e.g., hydrogel) 
using extrusion-based printing [70]. In this approach, the support bath can be filled either 
with a sacrificial material, in which case it will be removed after the printing of a matrix 
material, leaving out a self-supporting matrix, or with a stable matrix material, in which 
case a sacrificial material is printed within and removed after printing to create channels 
[70, 130, 165-169]. Independent of the particular approach (i.e., self-supporting matrix 
printing within support material or channel printing within matrix material), the bath 
material has to allow the needle motion during printing. In this regard, highly viscous 
polymer slurries, salt solutions, shear-thinning hydrogels, and micro-gels have been 
utilized [70, 130, 165-168]. This requirement significantly limits the number of available 
materials for this approach. In addition to extrusion-based printing, vat 
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photopolymerization printing was also utilized. Stereolithography was used to spatially 
cure photocurable hydrogels within vat to create embedded channels within hydrogels [132, 
170-172].   
In addition to the abovementioned approaches, “unit stacking” and “co-axial 
printing” approaches have also been utilized to develop vessels (or hollow tubes). In the 
unit stacking approach, cell spheroids were loaded in agarose hydrogel and printed to form 
a filament and supported by agarose only filaments. This technology enabled the 
fabrication of small vessel tubes that are 0.9-2.5 mm in diameter [63]. Byambaa et al. 
utilized “unit stacking” approach using GelMA hydrogels [112]. In this method, each 
GelMA strut is printed individually layer-by-layer on the building plane. To form channels, 
a sacrificial ink is printed, using a secondary print head, to replace one of the GelMA struts. 
This is the most commonly used bioprinting approach in the literature to fabricate channels. 
The advances in additive manufacturing technologies enabled the fabrication of complex 
3D scaffolds and medical devices [9, 27, 28, 82, 145, 146]. To fabricate clinically relevant 
and human scale tissue and organs, the development of 3D constructs with vascular 
networks is one of the major bottlenecks [96, 147-149]. Thus, there is a growing demand 
for novel approaches to create perfusable microchannels, with tunable sizes and shapes, 
within 3D printed hydrogel constructs. Hydrogel constructs with embedded microchannels 
are also essential for the development of organ-on-a-chip systems for fundamental studies 
relating to tissue development and disease and potentially be useful for drug testing [150].  
Although many approaches have been developed (as summarized above), there is 
still a need for novel approaches that are easily applicable, allowing the use of 
commercially available bioinks and desktop bioprinters to create user-defined and tunable 
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microchannels within 3D hydrogels. In this study, we address this gap. Here, a novel 
bioprinting approach is presented that enables 3D printing of user-defined and highly 
tunable channels (shape, size, and location within matrix hydrogel) embedded within a 
photocurable hydrogel matrix. In this approach, a photocurable hydrogel ink was printed 
layer-by-layer as usual, but partially photocrosslinked (for seconds) after the printing of 
each layer to allow self-supporting viscous construct. When the desired height was reached, 
the final matrix hydrogel layer was not exposed to light and s sacrificial hydrogel (Pluronic) 
was directly printed within this layer. The layer was then exposed to light to partially 
crosslink the matrix hydrogel and to confine Pluronic. This process was repeated as needed. 
Once the printing of the construct was finalized, it was exposed to light (minutes) to fully 
crosslink the construct and immersed in an aqueous solution to remove the sacrificial ink 
to form channels. Here, an important advance is reported as this approach does not require 
complex device modifications for bioprinters or complex synthesis and processing hurdles 
for the inks. It is also a reservoir and mold free (utilizes low amount of material) and allows 
flexibility to place channels at any height within the matrix. This approach allows 
bioprinting of cells with the matrix material and seeding of cells into channels after the 
sacrificial ink is removed. It could be envisioned that this approach can provide a robust 
platform for fabricating vascularized tissues and studying cell behaviors on diverse channel 





2.2 Materials and Methods 
2.2.1 Polymer Synthesis 
Methacrylated alginate (MeAlg) and methacrylated hyaluronic acid (MeHA) were 
synthesized by esterification of the hydroxyl group with methacrylic anhydride, following 
already established protocol [173, 174]. Briefly, 1 % (m/v%) polymer solution was 
prepared by dissolving 3 grams of low viscosity alginate (Alg, Alginic acid sodium salt 
from brown algae, Sigma) or sodium hyaluronate (HA, 60 kDa, Lifecore) in 300 mL 
deionized water in a three-neck flask. The solution was stirred and kept at ~1-4 °C in an 
ice bath. Subsequently, a 2M NaOH solution was used to adjust the pH of the polymer 
solution to 8-9. Then, 6 mL of methacrylated anhydride (MA, Sigma) was added dropwise 
to the 1% polymer solution, while 4M NaOH was simultaneously added to maintain the 
pH at 8-9. The whole amount of the MA was consumed with a span of 1.5~2 hours. After 
the addition of the MA, the pH was maintained by gradually pipetting 4M NaOH solution 
for 8 hours using an automated pH controller. The solution was kept at 4 °C overnight. The 
reaction was resumed the following day by adding 3mL of MA while maintaining the pH 
at 8-9. The material was then dialyzed (Spectra/Por®1 dialysis membrane, 6-8 kDa) against 
DI water for 4 days, followed by lyophilization. The percent modification was 
characterized using 1H NMR. 
2.2.2 Ink Preparation 
Ink formulations were prepared by dissolving MeHA (or MeAlg) at different 
concentrations in phosphate-buffered saline (DPBS) in the presence of a photoinitiator 
(405-410 nm), lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP). For instance, to 
prepare a 9% MeAlg, 0.001 g of LAP was dissolved in 2 ml of DPBS in a glass vial covered 
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with an aluminum foil. 0.18 g of MeAlg was then added into the solution, and the solution 
was stirred overnight at room temperature. Considering the previous reports [165], three 
different concentrations were used for MeAlg (5%, 7% and 9% (w/v)) and for MeHA (5%, 
10%, and 15% (w/v)). Sacrificial ink, Pluronic F-127 (Sigma), was prepared by dissolving 
4 g Pluronic in 10 ml of deionized water (40% (w/v) final solution) at 4 °C overnight.  
To prepare cell-laden ink, 1 ml of 18% MeAlg (or 30% MeHA) was mixed with  
20 μL RGD peptide (50 mg/mL, GRGDSPC - GenScript) and incubated at room 
temperature (RT) for 30 min. Then, the solution was mixed with 1 mL of cell suspension 
(hMSC, 2×106 cells/mL) under magnetic stirring, leading to a final concentration of 9% 
MeAlg (or 15% MeHA). Each ink formulation was transferred into a designated 10 mL 
syringe prior to printing.  
2.2.3 Rheological Characterization of Ink Formulations 
Malvern Ultra+ Rheometer was used to analyze the rheological properties of the ink 
formulations. All of the tests were performed using a flat plate geometry (20 mm) at 25 °C. 
For viscosity measurement, the shear viscosity was measured at shear rates from 0.01 to 
1000 s-1. Time sweep tests were done at a frequency of 1 Hz and an oscillatory strain of 
0.05 to investigate the change in elastic modulus (G’), viscous modulus (G’’), and phase 
angle (Φ). To investigate the evolution of the abovementioned rheological parameters 
during the 3D printing process, inks (9% MeAlg or 15% MeHA) were injected onto the 
lower plate of the rheometer, and time sweep tests were performed using a UV light 
apparatus (Malvern) connected to a UV light source (Omnicure S2000, 356 nm,  
40 mW/cm2). Light intensity was adjusted to compensate for the difference in the 
wavelength of the printer light source (405 nm) according to the molar absorptivity 
21 
 
spectrum of the photoinitiator (LAP) [175]. The ink was exposed to UV light in a stepwise 
manner mimicking the partial crosslinking (240 s for 9% MeAlg, 5 s for 15% MeHA) and 
fully crosslinking (15 s for 9% MeAlg, 90 s for 15% MeHA).  
2.2.4 Printer Parameter Optimization (Line Test) 
Ink formulations were used to print individual struts (lines) on a methacrylated glass slide 
at different pressures and speeds. The images of struts were captured by a microscope. 
Three random parts of each strut (from three samples per each group) were captured for 
analysis. The strut diameter was measured using ImageJ.  
2.2.5 Scaffold Design 
3D scaffold designs were created by Autodesk® Fusion 360™ and sliced with Slic3r in 
Repetier-Host to generate G-code files. For scaffolds with embedded channels, the matrix 
and the channel structures were sliced separately. The G-code file for the channel design 
was then incorporated into the G-code file for the matrix design. 
2.2.6 Preparation of Methacrylated Glass Slides 
In this study, surface modified glass slides (microscope slides) were used as the print 
substrate. The glass slides were modified with methacrylate as described previously [176]. 
Briefly, glass slides were first washed with DI water, then immersed in a 10M NaOH 
solution for 10 minutes. Subsequently, the glass slides were removed and washed with DI 
water, and dried. Glass slides were placed in a glass baking pan, and the surface of the glass 
slides were covered with 3-(Trimethoxysilyl)propyl methacrylate (TMS, Sigma) solution. 
After sealing the top of the pan with aluminum foil, the pan was put into an oven at 100 °C 
for 1 hour. After 1 hour, the temperature was increased to 110 °C for another 10 minutes. 
The glass slides were then washed with ethanol and rinsed with DI water and dried. 
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2.2.7 3D Printing of Sacrificial Hydrogel within the Matrix Hydrogel 
A novel approach was developed to 3D print vasculature within cell-laden hydrogels. Our 
approach utilizes 3D printing of a sacrificial hydrogel (or polymer) within the freshly 
printed matrix layer. Our approach is summarized in Figure 2.1. Briefly, the matrix ink 
(MeHA or MeAlg) was printed layer-by-layer as usual. After each layer, the construct was 
exposed to light to partially cure the printed matrix hydrogel (405 nm, 40 mw/cm2, 15 s for 
9% MeAlg and 5 s for 15% MeHA), which formed a self-supporting layer. Each layer was 
usually in the range of 500-600 μm but adjusted by adjusting the print speed or pressure of 
the matrix ink. When the desired matrix thickness was reached, one additional layer was 
printed, but it wasn’t exposed to light. The sacrificial ink was printed directly within this 
viscous layer, and the system was exposed to light. This process was repeated as required 
to complete the printing process. Once the printing of the desired construct was completed, 
the system was exposed to a final light exposure to fully crosslink the construct (405 nm, 
40 mw/cm2, 240 s for 9% MeAlg and 90 s for 15% MeHA). The construct was then 
immersed in an aqueous media (i.e., DPBS) to dissolve the sacrificial ink and form 
channels. A wide range of print speed and pressure was used for sacrificial hydrogel 
printing to investigate the effect of these parameters on strut size. The sacrificial matrix 
strut size was measured prior to the dissolution of the matrix, and the results were compared 
with the measured channel diameter. Channels were injected with red food coloring for 
visual clearance. Three random parts of each strut/channel (from three samples per each 




2.2.8 Cell Culture and Characterization 
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in the growth 
media (α-MEM (minimum essential medium) supplemented with 10% fetal bovine serum 
(FBS, Gibco) and 1% penicillin-streptomycin (Gibco)). For hMSC-laden bioink studies, 
two scaffold groups were printed including scaffolds with channels and without channels 
(control group). Scaffolds were cultured for 4 days, and live-dead staining was done at Day 
1 and Day 4 time points. For live-dead staining (Invitrogen), cells were stained with 
calcein-AM (“live”, 0.5 μL/mL) and ethidium homodimer (“dead”, 2 μL/mL) for 30 
minutes. Samples were immediately transferred to confocal laser scanning microscope 
(confocal and 2-photon scanning microscope, Leica) after staining to capture 3D scans. 
Three samples per group was prepared for viability studies. The viability was calculated 
by counting cells using ImageJ.  
Human umbilical vein endothelial cells (HUVECs, Lonza) were cultured for cell 
attachment studies on the channel surfaces. According to the vendor’s protocol, HUVECs 
were cultured in EGM-2 media (EGM-2 BulletKit, Lonza). Media was changed every two 
days to ensure a proper cell proliferation. Cells with 4-6 passage number were used in this 
study. Prior to the seeding process, the channels were injected with fibronectin (Invitrogen) 
solution (50 μg/mL) to enhance cell attachment. Cell suspension (3×107 cells/ml) was 
injected into the channels using a micropipette (0.1-10 μL tip). Scaffolds were then 
incubated at 37 ºC for 2 h, during which the scaffolds were flipped every 30 min. Scaffolds 
were then cultured for 7 h (during which they were flipped back one more time after the 
first 2 h), followed by culture on an oscillating shaker at a frequency of 1 Hz. The non-
adherent cells were flushed out of the channels by gently pipetting the media. The media 
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was changed every two days. The cell culture studies were performed in an incubator 
maintained at 37 ºC under 5% CO2. Cells in the channels were observed with a fluorescent 
microscope. At Day 14, the channels were gently flushed with DPBS (3X), and cells were 
fixed with 4% formaldehyde. Cells were permeabilized with 0.25% Triton-X (Sigma) and 
stained with Alexa Fluor™ 488 Phalloidin (Invitrogen) and with DAPI (Sigma) for F-actin 
and nuclei, respectively. 
2.2.9 Statistical Methods 
If not stated specifically, three samples per each group were used for all studies. The data 
were analyzed using KaleidaGraph. Data are presented as mean ±standard deviation. 
ANOVA with Tukeys HSD post hoc test of means was used to make comparisons between 





Figure 2.1 Schematic showing the novel printing approach to create complex channels 
embedded within photocurable hydrogels, including sequential printing of a photocurable 
matrix hydrogel and a sacrificial hydrogel within freshly printed matrix hydrogel layer, 
followed by a post-printing process to remove the sacrificial hydrogel to create channels.  
 
2.3 Results 
2.3.1 Preparation and Characterization of Inks 
Ink formulations were prepared from MeAlg and MeHA, with 90 % and 72 % 
methacrylation, respectively (Appendix A, Figure A.1). Based on the literature [165, 177], 
three compositions per each polymer is selected: 5%, 7%, and 9% (w/v) for MeAlg, and 
5%, 10%, and 15% (w/v) for MeHA. Pluronic (F-127) was used as a sacrificial ink (40% 
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(w/v)) [99]. The change in ink viscosity with shear rate for each formulation is shown in 
Figure 2.2. Viscosity of the ink formulations significantly increased with increasing 
polymer concentration for both MeAlg and MeHA. Shear thinning behavior (i.e., decrease 
in viscosity with increasing shear) is observed for MeAlg formulations, 15% MeHA ink 
and sacrificial ink. The viscosity values of MeAlg inks were significantly higher than that 
of MeHA (except for 15% MeHA, which has a viscosity similar to 5% MeAlg), despite the 
fact that MeHA inks had much higher polymer concentrations. 
 
 
Figure 2.2 Shear viscosity values with shear rate for MeAlg, MeHA, and Pluronic.  
 
2.3.2 Line Tests Results for Matrix Hydrogel Inks  
Line tests were performed on methacrylated glass slides to determine the optimal printing 
parameters (print speed and pressure) for selected needle-sizes (0.21 and  
0.30 mm in diameter). For instance, line test results for 9% MeAlg and 15% MeHA 
showing the printed strut size (μm) with print speed (mm/s) for three different print 
pressures (kPa) are given in Fig. 3. For MeHA inks, the strut size significantly increased 
with increasing pressure for each print speed. For instance, strut size increased from 600 
μm, for 138 kPa (20 psi), to 900 μm, for 207 kPa (30 psi), and to 1150 μm, for  
276 kPa (40 psi). Strut size decreased with increasing speed. When struts printed at  
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6 mm/s are compared with 10 mm/s, strut size decreased from 1150 to 900 μm, for  
276 kPa; 900 to 700 μm, for 207 kPa; and 650 to 500 μm, for 138 kPa. For 9% MeAlg, 
there was no significant change in strut size with pressure, but the strut size decreased 
gradually with increasing speed. Line test results for all of the ink formulations are given 
in Table 2.1. 
 
 
Figure 2.3 Line test results for 15% MeHA (A) and 9% MeAlg (B) printed using a 0.21 
mm diameter needle. 3D printed strut size (diameter) plotted against print-head speed for 





Table 2.1 Line Test Results Showing the Range of Printed Strut Size (diameter) with 
Respect to Print Speed and Extrusion Pressure, and Corresponding Needle Size for Each 
Formulation 
Ink formulation Needle size Print speed Pressure Strut size 
Hydrogel % (w/v) (mm) (mm/s) (psi) (μm) 
MeAlg 
5 0.21 10-30 5-15 300-1400 
5 0.30 10-30 5 800-1400 
7 0.21 10-30 10-30 250-1100 
7 0.30 10-30 5-15 350-1400 
9 0.21 6-10 20-40 500-1100 
9 0.30 10-30 10-20 500-1500 
MeHA 
5 0.21 6-10 3-8 400-1000 
5 0.30 NP* - - 
10 0.21 6-10 10-30 400-700 
10 0.30 6-10 5-15 300-1100 
15 0.21 6-10 70-90 500-800 
15 0.30 6-10 90 600-1300 
*: Not printable (NP) 
 
2.3.3 Rheological Properties of the Printed Matrix Hydrogels 
The evaluation of elastic modulus, viscous modulus, and phase angle was investigated 
using time sweep tests for 9% MeAlg and 15% MeHA (Figure 2.4). Green boxes in the 
figures show the light exposure periods, corresponding to partial crosslinking period (15 
and 5 s for MeAlg and MeHA, respectively) and complete crosslinking period (240 and 90 
s for MeAlg and MeHA, respectively). Our results showed that both formulations gelled 
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during the partial crosslinking period, and gelation progressed further during the complete 
crosslinking period. 
 
Figure 2.4 Rheological characterization of matrix hydrogel inks 9% MeAlg (A and C) and 
15% MeHA (A and D). Time-sweeps were performed to investigate the evolution of elastic 
modulus (G’), viscous modulus (G”), and phase angle (Φ). Inks were tested for ~80 s, 
followed by partial crosslinking (15 s for MeAlg and 5 s for MeHA) with UV light, and 
fully crosslinking (240 for MeAlg and 90 s for MeHA), mimicking the channel printing 
process. Green boxes show the light exposure region. 
 
2.3.4 Line Tests Results for Sacrificial Hydrogel Ink 
Line tests for sacrificial ink were done on methacrylated glass slides (Appendix A, Figure 
A.2) and within matrix (MeAlg and MeHA) hydrogels (Figure 2.5). In general, strut size 
increased with increasing needle size. For instance, when printed at 4 mm/s and 414 kPa 
pressure, strut size was 85 μm for 0.08 mm needle, 300 μm for 0.10 mm needle, and 400 
μm for 0.16 mm needle. Struts size increased with increasing pressure at a constant speed 
and decreased with increasing speed at a constant pressure (Appendix A, Figure A.2). 
Strut size was in the range of 85–380 μm, 200–800 μm, and 300–1200 μm for 0.08, 0.1, 
and 0.16 mm needle size, respectively. Sacrificial ink was then printed within the matrix 
hydrogels, and strut size was characterized before and after postprocessing to remove the 
sacrificial hydrogel (to create channels). Figure 2.5 shows the data for MeAlg hydrogel. 
Our results show that the strut size values were slightly higher within hydrogels as 
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compared to a glass slide (when printed at the same speed and pressure), but not 
significantly different. There was no significant change in strut size before and after the 
removal of the sacrificial ink. Note that struts (Figure 2.5B and D) became channels 
(Figure 2.5C and E) after the removal of the sacrificial ink. 
 
 
Figure 2.5 (A) Strut width (diameter), before (hydrogel strut) and after dissolution 
(channel) of sacrificial hydrogel with matrix (MeAlg) hydrogel, is plotted against print 
speed (mm/s) and pressure (psi). (B-C) Optical images of a representative strut before (B) 
and after (C) dissolution. (D-E) Representative confocal 3D scans of a strut (D) and a 
channel (E). In (D) rhodamine dye is mixed with Pluronic. In (E), the channel was injected 
with a solution containing rhodamine dye, and dye diffused out of the channel. Scale bars 
are 500 μm.  
 
2.3.5 Controlling Channel Size with Print Speed 
Print speed was used to control the printed sacrificial strut size, and hence, the channel size. 
Figure 2.6 shows the picture of the MeAlg hydrogel device with two channels (injected 
with red food coloring) with a gradient change in channel size. The channel at the top was 
printed with 1 mm/s stepwise decrease in print speed from 10 mm/s to 1 mm/s, creating a 
change in channel size from 250 μm to 1350 μm, followed by a 1 mm/s stepwise increase 
in print speed to 8 mm/s. For each print (speed) step, the print length (strut length) was 
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kept as 0.8 mm, except for the lowest speed, at which the print length was 1.6 mm. The 
channel at the bottom (Figure 2.6) was printed by decreasing the print speed from 9 mm/s 
to 1 mm/s at 1.8 mm print step size, forming a gradual increase in channel size from 400 
to 500 μm to ~500 μm, and up to ~1300 μm. In these print studies, the print pressure was 
kept constant at 621 kPa (90 psi), and 0.16 mm needle was used.  
 
 
Figure 2.6 3D printed MeAlg hydrogel with two channels with varying channel sizes. (i) 
and (ii) showing the print speed and channel size values plotted against print length, 
corresponding to the channels in the top picture.   
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2.3.6 3D Printing of Perfusable Channels Embedded within Hydrogels 
3D digital designs and their corresponding printed constructs are shown in Figure 2.7. 
Channels were injected with a red food coloring solution for visual clarity. In Figure 2.7A, 
MeAlg hydrogel (10 × 10 mm) is shown with various channel sizes, including 732 ± 6 μm, 
481 ± 46 μm, 423 ± 23 μm, and 367 ± 13 μm in diameter, from left to the right, respectively. 
Figure 2.7B shows a 3D printed MeAlg hydrogel (10 × 10 mm) with linear channels (800 
μm in diameter) on 2 different planes (in the z-direction), forming a checkerboard pattern. 
Figure 2.7C shows 2D converged channels (800 – 1200 μm) embedded within a MeAlg 
matrix (18 × 16 mm). In Figure 2.7D, MeHA hydrogel having wavy channels, in the form 
of sine waves with constant wavelength (8 mm) but decreasing amplitude (2, 1, 0.5, and 0 
mm), is shown. A connected closed-loop channel depicting ‘‘NJIT” letters within MeAlg 
is shown in Figure 2.7E. In Figure 2.7F, two sets of linear channels (3 individual channels 
per set, 500 μm in diameter) were printed at different x- and z-planes. Finally, a hydrogel 
device with two reservoirs (6 mm in diameter) and connected with two embedded channels 





Figure 2.7 Digital designs and corresponding 3D devices. (A) Linear channels with 
different sizes in a MeAlg matrix (10 x 10 mm) (channel sizes from left to right: 732 ± 6 
μm, 481 ± 46 μm, 423 ± 23 μm, 367 ± 13 μm). (B) MeAlg matrix (10 × 10 mm) with 2 
layers of linear channels (800 μm in diameter). (C) MeAlg matrix (18 × 16 mm) with 
converged channels (800-1200 μm). (D) Closed loop NJIT channel within MeHA hydrogel. 
(E) Injecting red dye into complex channels; (E) Top and side view of a hydrogel (16 × 14 
× 4 mm) with 2 sets of channels (500 μm in diameter) at different x- and z-plane; (F) 3D 
printed wavy channels constant wavelength (8 mm) but increasing amplitude (2, 1, 0.5, and 
0 mm). (G) Top and side view of a 3D printed device (30 × 20 mm) with 2 reservoirs (6 
mm in diameter) connected with 2 channels (800 μm in diameter) embedded in MeAlg 
hydrogel. All channels were injected with red food coloring. 
 
2.3.7 Cell Culture within Channels 
HUVECs were seeded and cultured up to 9 days within the channels. Figure 2.8 shows the 
confocal scanning images of the HUVECs. Our results confirmed cell attachment and 




Figure 2.8 Fluorescent images of the HUVECs cultured within channels (green showing 
F-actin and blue showing nuclei). (A) Maximum projection image from top. Cross-
sectional (B) and top (C) view of the channels. Scale bars are 100 μm. 
 
2.3.8 Bioprinting of Stem Cell-laden Hydrogels with Embedded Channels 
hMSCs were used to investigate the effect of our channel printing approach on cell viability. 
For this purpose, cells were mixed into our ink formulations (9% MeAlg and 15% MeHA), 
and hydrogels with and without channels were printed following our protocol. Figure 2.9A 
shows the representative confocal scanning images of the hMSCs (green indicates live cells, 
and red indicates dead cells) after printing. Figure 2.9B and C show the percent (%) cell 
viability up to 4-day culture. There was no significant change in the % cell viability 
between groups for 1-day and 4-day culture. We observed a slight decrease in % cell 
viability for cells cultured in MeHA without channels on Day 4. The cell viability was 
around 89–90% for cells within MeAlg (both with or without channels) for culture Day 1 
and 4, except for the without channels group at Day 4, which was slightly low (~86%). For 
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the MeHA group, cell viability was 88% and 90% on Day 1, and 86% and 81% at Day 4, 
with and without channels, respectively. 
 
 
Figure 2.9 (A) Confocal scanning microscopy images of hMSCs (green indicating live 
cells, and red indicating dead cells) bioprinted with MeHA and MeAlg hydrogels with and 
without channels and cultured for 1 day. (B-C) Corresponding % viability data for hMSCs 




A novel bioprinting approach was developed to print user-defined and tunable 
microchannels within photocurable hydrogels. Our approach enables the use of 
commercially available photocurable hydrogels and sacrificial polymers/hydrogels without 
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requiring any complex synthetic and processing procedures, desktop (dual-head) 
bioprinters (e.g., Allevi-2), or any hardware modifications. In this study, we used 
commercially available and commonly utilized MeAlg and MeHA hydrogels as the 
photocurable matrix ink and Pluronic (F-127) as the sacrificial ink. MeAlg and MeHA 
undergo radical polymerization in the presence of a photoinitiator when exposed to light, 
forming a crosslinked network (or a hydrogel). The degree of crosslinking can be 
controlled easily by controlling the methacrylate consumption, initiator concentration, and 
light exposure time [174]. Methacrylates also undergo a Michael-type addition reaction 
with thiols, thus allowing tethering of bioactive molecules containing cysteine groups [173, 
174]. This could be useful to incorporate bioactive cues into the hydrogel matrix when 
needed. For instance, we functionalized the matrix inks with RGD-peptide, following the 
protocol developed previously [173, 174], to enhance stem cell-matrix adhesion 
(Figure 2.9). 
In this study, we first investigated the printability of the ink formulations by 
performing single line (strut) tests on methacrylated glass slides. Methacrylation of the 
glass slides was not required and did not affect the printing parameters or printed line size 
but ensured strong adhesion of MeHA and MeAlg to the glass slide during line tests. For 
matrix hydrogels, two different needles (0.21 and 0.30 mm in diameter) were used to 
investigate the printability of these formulations. In addition to these two needles, we were 
able to extrude the sacrificial hydrogel using a 0.08 mm needle due to its superior shear 
thinning behavior as compared to matrix hydrogels (Figure 2.2). The main goal of these 
studies was to adjust the print speed and pressure to obtain good quality struts (or lines), 
i.e., continuous lines that are uniform in thickness without sagging or dragging. A wide 
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range of print pressure (34–621 kPa) and speed (6 – 20 mm/s) were used to create lines 
from 250 μm up to 1,500 μm in diameter (Table 2.1) for matrix hydrogels. As expected, 
higher pressures were needed to extrude the more concentrated formulations. For instance, 
a print pressure in the range of 483– 621 kPa was needed to extrude 15% MeHA, whereas 
the pressure was in the range of 138–276 kPa for 9% MeAlg (Figure 2.3). Note that the 
initial viscosity values for the MeAlg formulations were much higher than that of MeHA, 
but MeAlg formulations showed a higher degree of shear-thinning (Figure 2.2). We 
believe that this allowed the 9% MeAlg to be printed at lower pressures. We usually 
observed an increase in strut size with increasing pressure (as more material is extruded) 
at a constant speed and a decrease in strut size with increasing speed at a constant pressure. 
As shown in the results section (Figure 2.3), this was more pronounced in 9% MeAlg as 
compared to 15% MeHA (Figure 2.3). We believe that this is mainly due to the 
significantly higher print pressures for MeHA. As our printing approach requires partial 
crosslinking immediately after printing, we decided to use the formulations with the highest 
polymer concentrations (15% MeHA and 9% MeAlg) to reduce the partial crosslinking 
time, to allow sufficient support to the sacrificial hydrogel when the matrix hydrogel is in 
its uncrosslinked state, and to limit mixing between the matrix hydrogel and the support 
hydrogel. Thus, to form the matrix layers, 9% MeAlg was printed at a pressure of 138 kPa 
and a print speed of 10 mm/s, using 0.21 mm diameter needle. 15% MeHA was printed at 
a pressure of 552 kPa and a print speed of 10 mm/s, using the same needle. These 
conditions corresponded to ~500 μm diameter line (Figure 2.3) and led to printed layers 
that are ~500 μm in thickness. When needed, the matrix layer height was increased by 
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lowering the print speed (or increasing the pressure) to allow printing of larger size (>500 
μm) sacrificial lines within the matrix layer. 
For Pluronic (sacrificial ink), line test studies were crucial as the strut size directly 
determined the channel size (Figure 2.5). Line tests were first performed on the glass slides, 
to determine the relationship between print parameters and strut size. The strut sizes could 
be printed as low as 85 μm using a 0.08 mm needle. The next step was to use these 
parameters to print Pluronic in the matrix hydrogel. For this purpose, we first confirmed 
that the needle moved freely within the selected matrix formulations (15% MeHA as 
compared to 9% MeAlg) and that Pluronic did not mix with the selected matrix 
formulations when printed within. Note that it is not possible to use the free-form printing 
approach (discussed in the introduction) here, as formulations with much higher polymer 
concentrations are needed to support Pluronic when a support bath (filled with matrix 
formulation) is used, which would hinder the needle motion. Our approach overcomes this 
issue by taking advantage of a sequential crosslinking approach, completely eliminating 
the need for a bath of support material. 
In our approach (Figure 2.1), we printed the (photocurable) matrix ink layer-by-
layer as usual. To create self-supporting layers, each layer was briefly exposed to light (5 
s for MeHA, 15 s for MeAlg) to partially photocrosslink the layer. The ink formulations 
behaved like a viscous liquid (indicated by G’’ > G’) (Figure 2.4). When partially 
crosslinked, both G’ and G’’ increased, but G’ became larger than G’’, indicating a 
transition from a viscous behavior to an elastic behavior (gel point defined at G’ = G’’). At 
this stage, printed hydrogel layer was able to self-support itself. After the second layer of 
matrix material was printed, Pluronic was directly printed inside the top layer, and then the 
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layer was exposed to light for partial crosslinking. A final layer of matrix material was 
printed, followed by partial crosslinking. The construct was then exposed to light to fully 
crosslink the construct (240 s for 9% MeAlg and 90 s for 15% MeHA). At this stage, we 
observed a significant increase in G’ and a significant decrease in phase angle, confirming 
the complete gelation. The line test results showed that Pluronic strut size was slightly 
larger but not significantly different when printed inside the matrix hydrogel as compared 
to struts printed on the glass slides (at the same print pressure and speed). Struts were 
dissolved in DPBS within minutes to form channels, and there was no significant difference 
between the strut and channel size (Figure 2.5). This was due to the equilibrium swelling 
behavior of the matrix hydrogels in their fully crosslinked state, which limited the volume 
changes caused by swelling. One of the advantages of our approach is the ability to control 
the channel size by simply controlling the print speed. This allowed fabrication of 
individual channels with varying sizes, or a channel with varying size (Figure 2.6), without 
changing the print needle. 
To show the applicability of our approach, we developed a wide range of hydrogel 
devices with embedded channels, with different sizes, shapes, and complexity (Figure 2.7). 
We were also able to print a commonly used microchip design from MeAlg hydrogel. The 
size of these devices was not limited by the printing step but the ability to keep the devices 
in a humid environment. Larger devices tend to shrink with time, which is a gradual process 
and usually starts from the top surface, leading to slight deformations in the hydrogel 
(Figure 2.7G). This is typical behavior for hydrogels, and it could potentially be eliminated 
by keeping the hydrogels in a humidity-controlled chamber or in an aqueous media 
immediately after the printing process. 
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Finally, we successfully showed the compatibility of our printed devices for cell 
culture by performing two separate in vitro studies using HUVECs and hMSCs. These cell 
types are significant and commonly used models: hMSCs are used for tissue regeneration, 
and organ printing due to their ability to migrate, proliferate, and differentiate into many 
tissue types (muscle, cartilage, and bone) and HUVECs are important in understanding 
vascularization and angiogenesis. HUVECs were seeded inside the channels and cultured 
for 9 days to investigate cell adhesion and monolayer formation. Our results showed that 
cells attached inside the channels circumferentially and formed confluent layers. Note that 
cells that did not attach to the channels formed large aggregates and eventually died in the 
absence of adhesive peptides. Our future goal is to further investigate the endothelization 
and permeability of the endothelial layer. In a separate study, hMSCs were incorporated 
into the ink formulations to test the cell viability. The goal was to check if our printing 
approach had an effect on cell viability. Cell viability was 90% after 1 day of culture and 
slightly dropped (but not significantly) after 4 days of culture. But for MeAlg and MeHA 
without channels, this drop was about 5% and 10%, which is not surprising considering 
these were bulk hydrogels. The presence of channels enhanced viability as expected. 




In conclusion, a novel approach was developed to 3D print complex microchannels within 
photocurable hydrogels. Specifically, photocurable hydrogels were used as bioinks to print 
constructs layer-by-layer and exposing each printed layer to light ensured the formation of 
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self-supporting layers. This approach enabled direct printing of a sacrificial hydrogel into 
a freshly printed photocurable hydrogel layer. This freshly printed hydrogel layer confined 
and supported the sacrificial strut. After complete crosslinking of the hydrogel layer, the 
sacrificial hydrogel was washed away to form channels. Endothelial cells adhered and 
formed confluent layers within these channels. When incorporated into the photocurable 




NOVEL BIOINKS FROM UV-RESPONSIVE NORBORNENE-
FUNCTIONALIZED CARBOXYMETHYL CELLULOSE MACROMERS 
This chapter has been adapted from the publication: 
S. Ji, A. Abaci, T. Morrison, W.M. Gramlich, M. Guvendiren, Novel bioinks from UV-




Three dimensional bioprinting is an emerging field with a significant potential to create 
custom-designed and patient-specific “living” constructs using a patient’s own medical 
images and cells [9, 27, 28, 178]. 3D bioprinting could potentially eliminate organ shortage 
[59, 82, 142, 146] and enable development of patient-specific tissue models for 
personalized drug screening [145, 150, 179-181]. A recent frontier is in situ bioprinting for 
reparative or regenerative therapy, in which a living tissue is printed directly at the site of 
an injury or a defect [182-184]. Despite the strong potential of bioprinting and recent 
advancements in the bioprinting technology, there is a notable lack of diversity in bioinks 
which significantly hinders the widespread use of bioprinting.  
Three dimensional bioprinting enables layer-by-layer manufacturing of a living 
construct from bioinks, which are bioprintable formulations composed of cells that are 
usually supported with a hydrogel [89]. The requirement for live cell printing significantly 
limits the number of additive manufacturing technologies that are suitable for bioprinting 
[185]. Bioprinting technologies include extrusion-based direct ink writing (DIW), droplet-
based inkjet printing, and light-based approaches, including projection stereolithography 
and laser-induced forward transfer (LIFT) [10, 20, 185]. DIW is the most commonly used 
technique due to its availability, affordability, and ease of use. In DIW, a bioink 
43 
 
formulation is extruded through a blunt needle to form a self-supporting structure. In this 
process, the bioink should meet the basic requirements for extrusion-based bioprinting 
[186-188], such that it should (i) have a suitable viscosity, i.e., low enough for easy 
extrusion yet high enough for formation of self-supporting layers post-printing to minimize 
sagging, usually in the range of 30 to 6 × 107 mPa·s, and (ii) allow printing of living cells 
and support high viability (>90%) [89, 186, 187]. In addition, the bioink and its degradation 
products should be cytocompatible and should not induce an inflammatory response when 
implanted [187, 189].  
Most commonly used bioinks are formulated from cell-laden hydrogels due to their 
high-water content and properties mimicking native tissue microenvironment [44, 45]. A 
variety of hydrogel-based bioinks have been developed from synthetic (such as Pluronic 
[190, 191] and poly(ethylene glycol) [192]), or natural (gelatin [193-195], hyaluronic acid 
[130, 196], alginate [196, 197], chitosan [198], collagen [199, 200], fibrin [201], and silk 
[202, 203]) polymers/macromers , or decellularized tissue materials (e.g., heart, bone, liver, 
pancreas, etc.) [204, 205]. The building blocks of these formulations are usually modified 
to allow tunable viscosity and shape fidelity during printing process. Although innovative 
approaches have been developed to control printability including pre-crosslinking to 
control flow [192] or rapid crosslinking during or after-printing [206, 207], or designing 
shear thinning formulations [130, 208], novel bioink formulations are still needed to 
broaden the currently available bioink “library” and to develop stimuli responsive bioinks 
enabling control of bioprinted construct properties post-printing.  
This study is focused on carboxymethyl cellulose (CMC), a commonly used 
cellulose derivative. Cellulose is one of the most abundant and renewable natural polymers 
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[209, 210]. As a natural polymer, cellulose is inherently bioactive, biodegradable, and 
biocompatible [209]. The hydroxyl groups on its backbone structure allows 
functionalization of cellulose to tune its properties [211]. When compared to cellulose, 
CMC is highly soluble in water due to its carboxyl groups [212] making it an attractive 
building block for hydrogels. CMC-based hydrogels have been developed utilizing a wide 
range of crosslink mechanisms including physical and chemical crosslinking [13]. For 
instance, Nie et al. reported CMC-based hydrogels by crosslinking sodium CMC with 
AlCl3, and studied the effects of crosslinker, CMC concentration and temperature on 
hydrogel stiffness and degradation [16]. Chemically crosslinked CMC-based hydrogels 
have been developed using irradiation-initiated [17-19], photo-initiated radical [20, 21], 
enzymatic [22], and epoxide-opening reactions [23]. For instance, methacrylated CMC is 
synthesized to allow photo-initiated radical reaction to fabricate CMC-based hydrogels. 
These hydrogels were used to facilitate chondrogenic differentiation of encapsulated 
human mesenchymal stem cells (hMSCs) encapsulated within the hydrogels [21].  
Cellulose has been used a filler, or as a component, in ink formulations [213-216]. 
Majority of the studies utilized cellulose/alginate-based ink formulations, utilizing a range 
of cellulose derivatives (nanofibrillated cellulose, nanocellulose, and methylcellulose) and 
taking advantage of physically crosslinking ability of alginate with CaCl2 [217-222]. For 
instance, nanocellulose-alginate based bioinks were developed for 3D bioprinting of 
human chondrocyte-laden hydrogels for cartilage regeneration [217, 223]. Muller et al. 
developed alginate sulfate/nanocellulose bioinks but reported significantly compromised 
proliferation ability of chondrocytes during printing process [220]. Markstedt et al. 
developed bioinks from cellulose nanofibrils mixed with xylan for crosslinking [224]. Most 
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recently, methylcellulose (MC)-based hydrogels were printed utilizing the sol-gel 
transition, or lower critical solution temperature (LCST), allowing printing of MC-based 
hydrogels at 21℃ with high cell survival (80%) post-printing [225]. Li et al. developed 
highly thixotropic inks from alginate/methylcellulose blend hydrogels, and showed that the 
treatment of the printed constructs with trisodium citrate (TSC) significantly enhanced the 
interfacial bonding between printed layers [226]. Finally, Lewis group developed hydrogel 
composite inks composed of soft acrylamide matrix supported with cellulose fibrils, and 
crosslinked with clay [213]. They were able to selectively align cellulose nanofibrils during 
the printing process to develop 3D printed structures with anisotropic stiffness, which led 
to shape change on immersion in water. In this study, novel photocurable bioink 
formulations were developed directly from carboxymethyl cellulose (CMC) eliminating 
the need for alginate or other additives/components.    
Light-induced free radical polymerization of methacrylates or acrylates is a widely 
used approach in designing photoreactive bioinks, yet this reaction is not specific and leads 
to formation of a heterogenous network composed of kinetic chains. Thiol-norbornene 
photo-click chemistry is specific to norbornene and thiyl radicals (i.e., radicals from thiols) 
as compared to norbornene radicals (its own radicals) or nonradical thiols [227, 228]. This 
is important to achieve selectivity in crosslinking (crosslinkers containing multi-thiols) and 
tethering of biomolecules (containing mono-thiols). This mechanism ensures a more 
homogeneous crosslinking in a controllable manner [227, 229, 230]. Natural (such as 
alginate [231], hyaluronic acid [230, 232], and gelatin [233, 234] and synthetic polymers 
(such as poly(ethylene glycol) [229, 234, 235]) have been modified with norbornene group 
to fabricate photocurable, cell-laden hydrogels. Recently, CMC has been modified with 
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norbornene groups [212, 236] to develop renewable hydrogels. Gramlich group recently 
demonstrated high cell viability of encapsulated stem cells within norbornene 
functionalized CMC [237]. Motivated by these recent results, we focused on developing 
novel bioink formulations from norbornene functionalized CMC.      
In this study, we report two novel stimuli responsive bioink platforms from CMC 
for extrusion based bioprinting. CMC is functionalized with thiol-ene reactive norbornene 
(Nor) with an amide, norbornene CMC (NorCMC), or an ester linker, carbic (norbornene) 
functionalized CMC (cCMC). CMC was chosen as the building block for both of our bioink 
platforms due to its high availability and low cost, and high solubility in water. Light-
induced thiol-ene click chemistry enabling norbornene was selected as the functional group 
to achieve selective crosslinking and selective tethering of biomolecules. Printability of the 
bioink platforms was determined by the thiol-Nor ratio for each macromer concentration. 
CMC-based bioink platform allows tunable printability, stiffness, and high viability of 
bioprinted cells, and broadens the range of currently available bioink platforms. 
 
3.2 Material and Methods 
3.2.1 Polymer Synthesis 
The macromers, cCMC and NorCMC, were synthesized according to methods developed 
previously for cCMC [236] and NorCMC [237]. To synthesize cCMC, CMC (90 kDa, 0.7 
carboxymethyl groups per anhydroglucose unit, Sigma) was dissolved in reverse osmosis 
(RO) water at 1% (w/v). Then, 7.26 g of cis-endo-5-norbornene-2,3-dicarboxylic 
anhydride (carbic anhydride, TCI) was added to the CMC solution (per gram of CMC). 
The reaction was maintained for 2 hours while the pH of the reaction was adjusted at the 
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range of 9.0-10.5 by dropwise adding 10M NaOH. Subsequently, 10-fold volume of the 
reaction solution of ice-cold acetone was used to precipitate the reaction solution. The 
precipitate was collected by suction filtration and dissolved in RO water at 1% (w/v) and 
dialyzed (6-8 kDa) against RO water for 3 days followed by lyophilization. For NorCMC, 
sodium CMC (90 kDa, Sigma) was dissolved in RO water at 1% (w/v), and 0.592 g of 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC HCl), 0.356 g of N-
hydroxysuccinamide (NHS), and 0.4 mL of 5-norbornene- 2-ethylamine (NA) were added 
(per gram of sodium CMC). The reaction solution was stirred and maintained at room 
temperature for 18 hours. NaCl was added to the reaction solution, stirred at room 
temperature for 30 min, and the reaction solution was precipitated in 10-fold ice-cold 
acetone. The precipitate was dissolved in RO water at 1% (w/v) and dialyzed (6-8 kDa) 
against RO water for 3 days followed by lyophilization. The extent of the modification for 
both polymers was characterized using 1H NMR spectroscopy using a Bruker Avance Neo 
500 MHz spectrometer (NorCMC) and a Varian Inova 400 MHz spectrometer (cCMC). 
3.2.2 Cell Culture and Maintenance 
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in the growth 
media (MEM-α (Gibco), supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% 
penicillin-streptomycin (pen-strep, Gibco)) at 37 ℃ and 5% CO2. Growth media was 
refreshed every 3 days. Human umbilical vein endothelial cells (HUVECs, passage 5, 
Lonza) were cultured in EGM-2 media (EGM-2 Bullet Kit, Lonza). Media was changed 
every two days to ensure a proper cell proliferation. NIH 3T3 fibroblasts were cultured in 
DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% pen-strep (Gibco). Media 
was refreshed every 3 days.  
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3.2.3 Ink Preparation 
Ink formulations contained norbornene modified CMC (15% (w/v) for cCMC and 10% 
(w/v) for NorCMC) and 0.05% (w/v) lithium phenyl-2,4,6-trimethylbenzoylphosphinate 
(LAP, Allevi) in growth media. For instance, to prepare a 10% NorCMC, 100 mg of 
NorCMC was dissolved in 1 ml of 0.05% LAP stock solution in growth media in a glass 
vial, covered with an aluminum foil. The solution was stirred overnight at room 
temperature. To adjust the pH of the cCMC solution to pH = 7.5, 20 μL of triethylamine 
(Sigma Aldrich) was added to the cCMC solution.  
To prepare a bioink, 900 μL of LAP stock solution was used to dissolve the polymer. 
Then, the solution was mixed with 100 μL of cell suspension (hMSC, 3T3, or HUVEC; 
1×107 cells/mL) using a magnetic stirrer, leading to a final ink concentration of 15% cCMC 
(or 10% NorCMC). Each ink formulation was transferred into a BD Luer-Lok™ 10-mL 
syringe prior to printing. Prior to printing process, pre-calculated amount of the crosslinker 
(DL-dithiothreitol (DTT), Sigma) was added to the bioink formulation and stirred gently 
for 1 minute.  
3.2.4 Rheological Characterization of the Ink Formulations 
Malvern Ultra+ Rheometer (flat plate geometry, 20 mm, 1 mm gap) was used to analyze 
the rheological properties of the ink formulations. To investigate the crosslinking process 
in the absence of light exposure, time sweep tests were performed at a frequency of 1 Hz 
and an oscillatory strain of 0.05%. Elastic modulus (G’), viscous modulus (G’’), viscosity 
(γ) and phase angle (Φ) values were recorded. To investigate the photocrosslinking process, 
inks were casted on to the lower plate of the rheometer, and time sweep tests were 
performed using an optical kit (Malvern) connected to a UV light source (Omnicure S2000, 
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356 nm, 5 mW/cm2). Light intensity was adjusted to represent the intensity during printing 
process (405 nm, 40 mW/cm2) according to the molar absorptivity spectrum of the 
photoinitiator (LAP) [175]. The UV light was turned on for 4 minutes after 1 minute of 
equilibrium time during time sweep tests. Initial viscosity values refer to mean of the 
viscosity values measured for the first 1 min prior to UV exposure.   
3.2.5 Mechanical Properties of the Crosslinked Ink Formulations 
Malvern Ultra+ Rheometer (flat plate geometry, 8 mm) was used to measure the 
compressive modulus (Young’s modulus, E) of the samples. Two sets of disc-shaped 
hydrogel samples (1 mm in thickness and ~25 mm in diameter) were prepared via direct 
casting followed by UV exposure and bioprinting process. Samples were kept in DPBS for 
24 hours to ensure equilibrium swelling. The compression test was performed by applying 
a compressive normal force to the hydrogel sample using the upper flat plate geometry 
while monitoring the gap distance (where strain is equal to the gap - sample thickness). To 
ensure initial contact, an initial compressive force equal to 0.05 N was applied. The 
compressive force was increased continuously (0.1 mm/s) up to 2 N. The compressive 
modulus (E) was obtained by calculating the slope of stress-strain curve (using the linear 
range within 10% strain).  
3.2.6 Scaffold Design 
3D scaffold designs were created by Autodesk® Fusion 360™ and the 3D models were 
sliced with Slic3r in Repetier-Host to generate G-code files. A 15mm × 15 mm grid-like 
2-layer scaffold and a 12 mm × 8 mm 3-layer cuboid were designed for printability tests 




3.2.7 Line Test 
Ink formulations were used to print individual struts (lines) on a glass slide at different 
print pressures and speeds. The images of the printed struts were captured by a microscope. 
Three random parts of each strut (from three samples per each group) were captured for 
analysis. The strut diameter was measured using ImageJ). 10% Methacrylated hyaluronic 
acid (MeHA) was used as a control group.   
3.2.8 Printability Test 
In this study, an Allevi 2 (Allevi) bioprinter was used to perform all the printing processes. 
After mixing with DTT, the bioink formulations were immediately transferred to a 10-mL 
syringe, and the syringe was mounted on the printer. To test the printability, the bioink was 
used to print a 15 mm × 15 mm grid-like 2-layer scaffold on a methacrylated glass slide 
(following the surface treatment protocol described previously [176]). The elapsed time 
was also recorded after mixing DTT in bioink formulation. Printing parameters were 
optimized with respect to this elapsed time to print uniform grids. Methacrylated 
hyaluronic acid (MeHA) was used as a control group.  To print thick hydrogel scaffolds (> 
3 mm), 30% Pluronic F-127 was used as a support ink. After crosslinking process, the 
scaffolds were immersed in DPBS at 4 oC to remove Pluronic support. To print multi-
material scaffolds, cCMC 1:4 and NorCMC 1:2 were prepared as mentioned. To 
distinguish different inks, 100 μL of food color was added to cCMC 1:4. 
3.2.9 3D Bioprinting of Cell-laden Hydrogels 
Cell-laden bioink (15% cCMC or 10% NorCMC) was printed on methacrylated glass slides 
at optimized parameters obtained from printability tests. The printed cell-laden scaffolds 
were immediately transferred into non-treated 6-well plates and 5 mL of growth media was 
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added into each well. Methacrylated hyaluronic acid (MeHA) was used as a control group.   
3.2.10 Cell Viability Tests 
Cell-laden hydrogels were cultured for 7 days, and live-dead staining was performed at 
Day 1, 4, and 7 to characterize the viability of the encapsulated cells. Cell-laden hydrogels 
were washed with DPBS and then stained with calcein-AM (“live”, 0.5 μL/mL) and 
ethidium homodimer (“dead”, 2 μL/mL) for 15 minutes. Samples were washed with DPBS 
and transferred to confocal laser scanning microscope (confocal and 2-photon scanning 
microscope, Leica) to capture fluorescent images of the cells. Two samples per group was 
prepared for each time points and 3 random regions of the gel were scanned. The viability 
was calculated by counting cells using ImageJ.  
3.2.11 Statistical Methods 
If not stated specifically we used three samples per each group for all studies. The data 
were analyzed using KaleidaGraph. Data are presented as mean ± standard deviation. 
ANOVA with Tukeys HSD post hoc test of means was used to make comparisons between 
sample groups.  
 
3.3 Results 
3.3.1 Bioink Formulations 
In this study, two distinct bioink formulations were developed from norbornene 
functionalized CMC (Figure 3.1), either with an amide, NorCMC, or an ester linker, 
cCMC. 1H NMR results confirmed 30% and 20% functionalization for cCMC and 
NorCMC, respectively (Appendix B, Figure B.1). The compositions of the bioink 
formulations are given in Table 3.1. Bioinks were formulated at 15% cCMC and 10% 
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NorCMC, with thiol to norbornene ratio (T:NB) equal to (1:4), (1:2), and (1:1).  
 
 
Figure 3.1 Chemical structure, modification reaction, and crosslink mechanism of (A) 
NorCMC and (B) cCMC.  
 
Table 3.1 Composition, Corresponding Viscosities, and Autogelation Time of Tested Ink 
Formulations  
Ink formulation Polymer 
concentration 




cCMC (1:4) 15% (1:4) 0.8±0.10 91 
cCMC (1:2) 15% (1:2) 1.2±0.10 57 
cCMC (1:1) 15% (1:1) 1.5±0.03 29 
NorCMC (1:4) 10% (1:4) 0.8±0.09 >180 
NorCMC (1:2) 10% (1:2) 1.2±0.09 49 




3.3.2 Rheological Test Results  
The initial shear viscosities of the bioink formulations were in the range of 0.8-2.8 Pa•s 
(Table 3.1). The gelation behavior of the formulations was characterized with time sweep 
experiments, in which the elastic modulus (G’), viscous modulus (G’’), and phase angle 
(Φ) values were recorded (Figure 3.2). For all of the formulations, autogelation behavior 
is observed within 3 hours in the absence of UV light. The gel point, i.e., onset of gelation, 
and the elapsed time for equilibrium for each formulation are summarized in Table 3.1. 
The gel point decreased with increasing T:NB, or increasing crosslinker concentration. For 
cCMC, gelation time significantly increased from 29 min (1:1) to 91 min (1:4). For 
NorCMC, gelation time values were 26, 40, and greater than 180 min, for (1:1), (1:2), and 
(1:4), respectively.  
 
 
Figure 3.2 Time sweep test of ink formulations without light exposure. (A-C) 10% 
NorCMC with thiol to norbornene ratio, (T:NB) equal to (1:4) (A), (1:2) (B), and 1:1 (C). 
(D-F) 15% cCMC with (T:NB) = 1:4 (D), 1:2 (E), and 1:1 (F).  
 
To investigate the gelation under light exposure, samples were exposed to UV light 






independent from T:NB, gel point was equal to ~18 s, and it took approximately 120 s for 
crosslinking reaction to reach equilibrium. For NorCMC, the gelation time and equilibrium 
time were equal to ~5 s and ~60 s, respectively. The magnitude of the equilibrium shear 
modulus (G’) was determined by the composition of the ink formulation, such that a higher 
(T:NB) resulted in a higher G’. For cCMC formulations, the equilibrium values for G’ were 
equal to ~3200 Pa for (1:4) and ~9300 Pa for (1:2). For NorCMC, the equilibrium values 
for G’ were equal to ~4600 Pa for (1:4) and ~8700 Pa for (1:2). 
 
 
Figure 3.3 Time sweep test of ink formulations under light exposure for: (A) NorCMC 
(1:4) and (B) cCMC (1:4). Green area denotes the UV exposure period. 
 
3.3.3 Mechanical Tests Results 
To probe the mechanical properties, the compression moduli were measured using 3D 
printed samples from all of the ink formulations. As shown in Figure 3.4A, for the same 
macromers, higher (T:NB) resulted in higher compressive moduli. For 15% cCMC, the 
compressive modulus increased by ~7-fold (from 46 to 316 kPa) when the (T:NB) 
increased from (1:4) to (1:2). The same trend was observed for 10% NorCMC, but the 








3.3.4 Swelling Tests Results 
Swelling tests were conducted on 3D printed samples (Figure 3.4B). Our results showed 
that increasing (T:NB) resulted in a 1.8 fold decrease in the swelling ratio (from 26 to 14 




Figure 3.4 (A) Compressive modulus (E) values of the 3D printed hydrogels from bioink 
formulations. p<0.005 for cCMC (1:2), as compared to the rest of the sample groups, and 
for NorCMC (1:2), as compared to the other groups. (B) The equilibrium swelling ratios 
values of the 3D printed hydrogels. p<0.005 for cCMC (1:4) and for NorCMC (1:2), as 
compared to cCMC (1:2) and NorCMC (1:2). 
 
3.3.5 Line Test Results 
Figure 3.5 shows the line test results for 15% cCMC and 10% NorCMC. MeHA (10%) 
was used as a control group. In general, strut size increased with increasing print pressure 
and decreasing print speed. For instance, at 10 mm/s, the line width increased from 920 to 
1390 m for cCMC, from 850 to 1790 m for NorCMC, and from 1110 to 1720 μm for 
MeHA, when the pressure was increased from 138 kPa (20 psi) to 276 kPa (40 psi). When 
printed at 20 mm/s and 138 kPa print pressure, it was possible to achieve 630 μm for cCMC, 





Figure 3.5 (A) Line test results for 15% cCMC, 10% NorCMC and 10% MeHA bioinks. 
Error bars denote standard deviation for n ≥ 5. (B) Printability tests for 15% cCMC and 
10% NorCMC for different (T:NB). The x-axis shows the elapsed time after mixing the 
crosslinker (DTT) with the ink formulation. Printability test result for 10% MeHA is given 
as a control. 
 
3.3.6 Printability Test Results 
Ink formulations from cCMC and NorCMC (both formulations with (T:NB) equal to (1:4) 
and (1:2)), were used to print grid-like scaffolds (Figure 3.5) to investigate printability. 
The pressure was set at 138 kPa (20 psi) at the beginning (for 30 min delay time) and 
gradually increased to 276 kPa (40 psi, for 60 min delay time) and 345 kPa for (50 psi, for 
90 min delay time) to compensate the increment of the ink viscosity due to autogelation. 
The print speed was controlled between 5 mm/s and 10 mm/s to print the gel with a uniform 
shape. Due to autogelation, ink formulations were not extrudable after a certain time for 
each formulation that was marked with a cross sign in Figure 3.5. Dual material printing 
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was used to bioprint thick hydrogel scaffolds (NorCMC (1:2)) supported with sacrificial 




Figure 3.6 Pictures showing multi-material printing of thick (>3 mm in height) scaffolds. 
(A-B) Top (A) and side (B) views of NorCMC (1:2) scaffold printed with Pluronic (red). 
(C-D) Scaffold after Pluronic is dissolved in DPBS. (E-F) NorCMC (1:2) scaffolds printed 
with fast degrading cCMC (1:4) (red). Scale bars are 5 mm. 
 
3.3.7 Bioprinting Test Results 
Figure 3.7A shows the cell viability data (in percentage) for hMSCs, 3T3 cells, and 
HUVECs. Note that cCMC sample group degraded in the medium after Day 4.  
Figure 3.7B shows the confocal images of the stained cells, in which the green indicates 
live cells, and the red indicates dead cells. In the side view images, the range of cells in the 
vertical direction was different due to the different swelling properties for each ink 




Figure 3.7 (A) Plots showing % cell viability with culture time for cells (hMSCs, NIH 3T3 
cells and HUVECs) cultured within bioprinted cCMC, NorCMC and MeHA hydrogels.  
* indicates the cCMC (1:4) sample group that degraded before Day 7. (B) Confocal 
fluorescent images of cells (hMSCs, NIH 3T3 cells and HUVECs) within bioprinted cCMC, 
NorCMC and MeHA hydrogels (green indicating live cells and red indicating dead cells). 
(Scale bars are 200 μm) For hMSC, αp < 0.005 cell viability for MeHA at Day 1 vs. at  
Day 4 and at Day 7, and at Day 4 vs. at Day 7; cell viability for cCMC (1:4) as compared 
to NorCMC (1:4) at Day 1; cell viability for NorCMC (1:2) as compared to MeHA at Day 
7; βp < 0.0001 NorCMC (1:4) vs. MeHA at Day 7. For NIH 3T3 cell line, αp < 0.005 cell 
viability for MeHA at Day 1 vs. Day 4 and Day 7; cell viability of MeHA as compared to 
NorCMC (1:2) and (1:4) at Day 1 and at Day 7; γp <0.005 for NorCMC at Day 1 vs. Day 
7. For HUVECs, αp < 0.005 cell viability for NorCMC (1:4) and (1:2) at Day 1 vs. Day 7; 




Here, we report novel bioink formulations from norbornene modified, cellulose-based 
macromers for the first time. Cellulose-based materials are promising candidates as bioinks 
due to their inherent bioactivity, abundance, and low cost. In this study, two distinct 
macromers were developed by functionalizing CMC with an amide (NorCMC) or an ester 
linker (cCMC) with 30% and 20% functionalization for cCMC and NorCMC, respectively. 
These degrees of functionalization were selected because hydrogels at the same thiol to 
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norbornene ratio and low solids content (4 wt% polymer) yielded similar compression 
modulus values [74,75]. Our previous studies (utilizing the same extrusion-based printer) 
revealed that an initial viscosity in a range of 1-10 Pa•s was ideal for a non-shear-thinning 
hydrogel when a 27-gauge needle was used [196]. To adjust the viscosity of the inks within 
this range, polymer concentrations were set to 15% for cCMC and 10% for NorCMC, due 
to differences in solubilities of the macromers. A higher concentration of cCMC was used 
as compared to NorCMC to yield similar bioink initial viscosities. The cCMC polymer is 
significantly easier to dissolve than NorCMC because additional carboxylic acid groups 
are introduced through the functionalization reaction (Figure 3.1). This behavior translated 
into similar bioink viscosities at different polymer concentrations. Additionally, since the 
norbornenes are connected to the CMC with different functional groups, degradation 
behavior was expected to be different with the ester linkages of cCMC degrading earlier 
than the amides of NorCMC. 
Crosslinker, or thiol, to norbornene ratio (T:NB) was systematically increased, 
from (1:4), (1:2) and to (1:1), to investigate the effect of (T:NB) on bioink properties. For 
cCMC, the viscosity values did not change significantly with (T:NB). However, for 
NorCMC, we observe a significant increase in viscosity with increasing (T:NB), such that 
a 2-fold increase in viscosity is observed when (T:NB) increased from (1:4) (0.8 Pa•s) to 
(1:1) (2.8 Pa•s). This we believe is due to the spontaneous crosslink of the macromers in 
the absence of UV light, i.e., autogelation process. Rheological evaluation of the 
formulations revealed autogelation in all formulations, but the gel point (onset of gelation) 
decreased significantly with increasing (T:NB). The mechanism of this phenomena has not 
been understood yet, but it is previously reported that the autogelation accelerates with 
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increasing thiol and norbornene concentrations, increasing temperature, dissolved oxygen, 
and acidic conditions [212]. Previous chemical characterization of the autogelation has 
indicated that it is still a thiol-norbornene reaction, which must be initiated through radicals 
spontaneously produced in the solution [50]. Future work aims to understand the origin of 
these radicals. Note that cCMC is acidic when directly dissolved in the growth media or 
DPBS (pH reaching to ~4) due to the presence of carboxylic acid units in the carbic groups. 
Therefore, we adjusted the pH to 7.6 (as described in the experimental section) to mainly 
eliminate cell viability issues. We found that cCMC could form a gel within few minutes 
when the pH is not adjusted (Appendix B, Figure B.3). Considering the autogelation 
behavior of our macromers, the gelation time (gel point) is considered as a critical 
parameter for planning the printing process, since these hydrogels were not extrudable 
when gelled. Considering the time required for pre-printing process, we decided to 
eliminate the macromer formulations with gel point below 1 hour (Table 3.1 and  
Figure 3.5). Thus, macromer formulations with highest (T:NB), (1:1), for both macromers 
were eliminated. 
Norbornene groups allowed the macromers to be photoresponsive which can lead 
to crosslinking in the presence of a photoinitiator (LAP) and a crosslinker (DTT) when 
exposed to light. Rheological tests in the presence of a UV light source allowed us to 
determine the photocrosslinking parameters to be used during the bioprinting process. For 
cCMC, it required ~18 s to gel and ~120 s to completely crosslink, which directed us to set 
the partial crosslink time to be 30 s and the post-print crosslinking time to be 120 s  
(Figure 3.3). The crosslink setting for NorCMC was also set as 10 s for partial crosslinking 
and 90 s for post-print crosslinking. The printability tests were conducted to evaluate the 
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printability and to optimize the print parameters (print speed, print pressure, layer height, 
blue light exposure time). In the printing phase, some deviations between the rheological 
data (Figure 3.2) and printing results (Figure 3.5) were observed. In Figure 3.2E, the 
gelation time of cCMC 1:2 was 57 min, which means that the available time for printing 
should be around 1 hour. However, as shown in Figure 3.5, cCMC 1:2 was not printable 
after 30 min. We believe that this is caused by the undermixing of the gel solution and the 
crosslinker leading to localized gelation in the syringe due to increased thiol concentration.  
Vigorous mixing such as vortex is not suitable for viscous ink formulations, and ink can 
gel during gentle, but longer, mixing process. Due to these concerns, cCMC 1:2 was 
eliminated from further study.  
Our results indicate that the thiol to norbornene ratio (T:NB) of the bioink 
formulation, controlled by the crosslinker concentration, also affects the mechanical 
properties of the hydrogel (Figure 3.4A). Normally, at the molecular level, increasing 
crosslinker concentration leads to an increase in the compressive modulus (Young’s 
modulus, E). Thus, as expected the E values increased significantly with increase in (T:NB) 
from (1:4) to (1:2) for both cCMC and NorCMC. 
For each bioink formulation, we compared the cell viability with culture time for 
each cell line. For instance, hMSC viability decreased from 96% at Day 1 to 90% at  
Day 4, and to 84% at Day 7 for MeHA control group. Note that MeHA is not degradable, 
and this could potentially eliminate the ability of the hMSCs to spread and proliferate. 
However, hMSC viability was not significantly different for other degradable formulations, 
such that cell viability remained stable within 92-93% interval for cCMC (1:4), 95-97% 
interval for NorCMC (1:4), and 97-93% interval for NorCMC (1:2). When NIH 3T3 cells 
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are considered, cell viability decreased for NorCMC (1:2) from 92% at Day 1 to 83% at 
Day 7, and for MeHA from 97% at Day 1, to 88% at Day 4, and to 87% at Day 7. Cell 
viability did not show a significant change and remained constant within 93-83% for cCMC 
(1:4) and within 91%-83% for NorCMC (1:4). For HUVECs, cell viability decreased from 
93% at Day 1 to 86% at Day 7 for NorCMC (1:4) and from 91% at Day 1 to 86% at Day 
7, whereas the changes were not significant between Day 1 and Day 4 (including cCMC 
group), and Day 4 and Day 7. Cell viability for MeHA group remained within 97-93%. 
Our results showed that the decrease in cell viability for the NorCMC and cCMC 
formulations is not trivial, and dependent on the cell type and culture period. As we did not 
use any commonly used cell-adhesive peptides (such as RGD), we believe that cell 
variability could potentially be further enhanced, if needed. We also compared the cell 
viability between sample groups (bioink formulations) for each cell line at each culture 
Day. For hMSCs, cell viability for cCMC (92%) was lower than that for NorCMC (1:4) 
(97%) at Day 1. No significant difference was observed between sample groups at Day 4. 
However, cell viability for MeHA (84%) was lower than that for NorCMC (1:2) (93%) and 
for NorCMC (1:4) (97%) at Day 7. For 3T3 cell line, cell viability for MeHA (97% at  
Day 1, 87% at Day 7) was higher than that for NorCMC (1:2) (92% at Day 1, 83% at  
Day 7) and NorCMC (1:4) (91% at Day 1, 83% at Day 7) at Day 1 and Day 7. When 
HUVECs are considered, cell viability for MeHA (98%) was higher than cell viability for 
NorCMC (1:2) (91%) and NorCMC (1:4) (93%) at Day 1. No significant difference was 
observed between sample groups at Day 4 and Day 7. We believe that a lower cell viability 
at Day 1 could potentially indicate issues during printing process, such as cell damage due 
to shear or light exposure. One way to avoid this is to increase the bioink viscosity to protect 
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the cells. For instance, MeHA bioinks were much viscous leading to higher cell viability 
at Day 1.    
The 15% cCMC (1:4) sample degraded and disintegrated by Day-7 while the similar 
NorCMC (1:4) did not because of the reduced degradation afforded by the amide 
connectivity versus the ester groups connecting the norbornenes to the CMC. Hydrolytic 
degradation of the cCMC bulk hydrogels was previously reported, such that for 4% cCMC 
with (T:NB) equal to (1:4), 30% mass loss was reported within 24 hour incubation, which 
increased to ~50% after 7 days [236]. This behavior was not observed for NorCMC 
hydrogels [237]. In good agreement with the swelling data (see above), we observed 
differences in the confocal side view images (Figure 3.7B) of the 3D printed samples. For 
instance, vertical distribution of the cells within NorCMC (1:4) was about twice thicker 
than NorCMC (1:2), which corresponded to the difference in the swelling ratio (23.4 for 
NorCMC (1:4), 12 for NorCMC (1:2)). For cCMC (1:4), cells distributed more sparsely 
when compared to that for NorCMC. We believe that this was due to hydrogel degradation 
as discussed above.  
 
3.5 Conclusions 
In conclusion, we report a two norbornene-modified cellulose-based macromers as novel 
bioink materials. Polymer concentration and thiol: norbornene ratio (T:NB) were 
optimized to prepare printable bioink formulations from cCMC (with (T:NB) = (1:2) and 
(1:4)) and NorCMC (with (T:NB) = (1:4)). All the ink formulations were able to 
encapsulate cells (hMSCs, NIH 3T3 fibroblasts, and HUVECs), and to be printed as cell-
laden scaffolds. We believe that these two cellulose-based macromers broaden the bioink 
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POLYESTER-BASED INK PLATFORM WITH TUNABLE BIOACTIVITY FOR 
3D PRINTING OF TISSUE ENGINEERING SCAFFOLDS 
This chapter has been adapted from the publication: 
S. Ji*, K. Dube*, J.P. Chesterman, S.L. Fung, C.Y. Liaw, J. Kohn, M. Guvendiren, 
Polyester-based ink platform with tunable bioactivity for 3D printing of tissue engineering 
scaffolds, Biomaterials Science 7(2) (2019) 560-570. *Co-1st Author 
 
4.1 Introduction 
Over the last decade, 3D printing has become a promising manufacturing approach for a 
wide range of medical applications, including dentistry, tissue engineering and 
regenerative medicine, medical devices, anatomical models, and pharmaceutics [9, 46, 
238]. 3D printing enables fabrication of custom-designed and patient-specific tissue 
engineering scaffolds and devices using the patient’s own medical images, which is not 
possible with conventional scaffold fabrication techniques [82, 239-244]. In addition, 
conventional techniques generally lack precise control of pore size, geometry, 
interconnectivity, spatial distribution, and the overall scaffold architecture [245-247]. 
These are crucial parameters for a biomaterial to promote the vascularization and tissue 
ingrowth that are necessary to establish functional integration of the scaffold [190, 191, 
248, 249]. However, most devices currently printed using polymeric biomaterials only 
serve as a structural support; they permit, but do not promote, biological function [250, 
251]. This limitation is due to the lack of bioactivity of common printable polymers, such 
as poly(lactic acid) (PLA) and polycaprolactone (PCL). Due to their thermoplastic and 
semi-crystalline behavior, PLA and PCL can be easily extruded as filaments for fused 
deposition (FDM) printing or directly printed from melt using direct ink writing (DIW). 
Semi-crystalline behavior contributes to dimensional stability during melt to solid 
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transition and to mechanical properties (stiffness). Both PLA and PCL are extensively used 
to 3D print tissue fixation devices and tissue engineering scaffolds, in particular for 
musculoskeletal tissue [252, 253]. Although significant progress has been made to develop 
novel printable soft material platforms (including hydrogels and elastomeric systems) [70, 
168, 254-259], the progress in biodegradable “stiff” polymers is very limited. 
From a materials-perspective, a polymeric biomaterial should meet the 
requirements for printing to be considered an “ink”. Rheological properties of the polymers 
are crucial to determine their printability. For extrusion-based printing, the polymer melt 
must flow at the print temperature (Tp) (usually below 250 ˚C for commercially available 
printers); thus, the loss modulus (G") must be greater than the storage modulus (G') at 
Tp.[13] The melt viscosity should be below 10
6 mPa·s to allow flow under applied pressure 
(usually ≤110 psi for commercially available printers) [260]. In addition, the polymer must 
have a reversible and fast melt to solid phase transformation (within minutes) to rapidly 
melt in the hot nozzle and to rapidly solidify when extruded from the nozzle [261]. 
In addition to printability, the ideal polymeric biomaterial should have sufficient 
mechanical properties (stiffness, toughness, etc.) to provide structural integrity, thereby 
enabling direct implantation, and should be biodegradable to allow replacement of the 
scaffold by newly grown tissue [262-265]. The latter requires the use of polymers that 
hydrolytically or enzymatically degrade to biocompatible, resorbable monomers that can 
be easily excreted from the body.  
Finally, polymeric biomaterials often require bioactivity to control cell function, 
including cell migration (infiltration), proliferation, and phenotype preservation or 
differentiation [15, 266-268]. Naturally occurring polymers usually display inherent 
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bioactivity, which is not the case for synthetic polymers. Thus, it is of great interest to 
design functionalizable synthetic polymers for 3D printing. Polymers can be functionalized 
at the end groups or along the backbone by adding pendant reactive groups, such as 
carboxylic acids [269], amines [270], or hydroxyls [271], One of the most commonly 
utilized approaches is click-based conjugation chemistry using click-ready pendant groups, 
such as alkenes, alkynes, azides, and epoxides [272, 273], Click chemistry has been 
employed for a wide range of applications including bioconjugation, labelling, surface 
functionalization, polymer synthesis and modification, and hydrogel modification [272, 
274-276],  
In this study, we developed a novel platform of 3D printable biodegradable 
polymers with tunable bioactivity via click-based chemistry for extrusion-based printing, 
with printability and stiffness comparable to PLA. A wide range of tyrosine-derived 
polycarbonates with tunable properties have been developed previously [277-281], In this 
work, the synthetic design was based on 4-hydroxyphenethyl 2-(4-hydroxyphenyl)acetate 
(HTy), which is an ester derived from Tyrosol and 2-(4-hydroxyphenyl)acetic acid. Both 
compounds are naturally occurring organic molecules found in olive oil [282, 283], HTy 
has been shown to be antioxidant, anti-stress, and antibacterial [282, 283], p-
Phenylenediacetic acid (PDA) was incorporated into the synthetic design to tune thermal 
processability by enhancing crystallinity via π-π stacking interactions. To enable 
functionalizability, glutamic acid derivatives were incorporated into the synthetic design 
without deteriorating printability and stiffness. Glutamic acid is a diacid with a pendant 
amine group, which can be easily modified to incorporate various functional groups. In this 
study, we focused on alkyne and alkene functionality for commonly utilized click-based 
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conjugation chemistry.  
To demonstrate the utilization of this novel ink platform, osteogenic differentiation 
of stem cells was studied using 3D printed scaffolds. 3D printed scaffolds were 
functionalized with azide-Heparin (az-Heparin) via click chemistry. Heparin is a linear 
polysaccharide found in most biological tissues. Heparin is known to sequester growth 
factors, enzymes, and matrix proteins. Thus, it is extensively used for the sustained release 
of growth factors including bone morphogenetic protein-2 (BMP-2) (for up to 20 days) 
[284, 285] to enhance bone regeneration.[286] Our results showed a significant increase in 




4.2.1 Synthetic Procedures 
4.2.1.1 Monomer Synthesis.  Monomers including 4-hydroxyphenethyl 2-(4-
hydroxyphenyl) acetate (HTy) (Figure 4.1A), hex-5-enoylglutamic acid (Gluhexenamide) 
(Figure 4.1B), and pent-4-ynoylglutamic acid (Glupentynamide) (Figure 4.1C) were 
synthesized as described in the experimental section of Appendix C. 
4.2.1.2 Polymer Synthesis.  A general procedure for the polymer synthesis ((Figure 4.1) 
is provided here and further details can be found in the Experimental Section of the 
Appendix C. In a round bottom flask, 1 equivalent of diol, 0.97 combined equivalents of 
diacid, and 0.33 equivalents of 1,4-dimethylpyridinium p-toluenesulfonate (DPTS) were 
combined with dichloromethane (DCM) and magnetically stirred for 15 min. The stirring 
reaction mixture was cooled for 30 min in an ice bath and then 2.1 equivalents of N,N’-
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diisopropylcarbodiimide (DIC) were added. The stirring reaction mixture was kept in an 
ice bath for 1 hour and then allowed to gradually warm to room temperature overnight. 
After 16 hours, the reaction mixture was precipitated by gradually adding isopropanol (5X 
DCM volume) while stirring. The precipitate was collected by vacuum filtration, 
redissolved in DCM, and reprecipitated using isopropanol, twice. The final precipitate was 
collected by vacuum filtration and dried in a vacuum oven at 40 ˚C for 48 hours. 
4.2.2 Monomer and Polymer Characterization 
The synthesized monomers and polymers were characterized by 1H NMR spectroscopy 
using Varian 400 MHz and 500 MHz NMR spectrometers with dimethyl sulfoxide-d6 
(DMSO-d6) as solvent and peak shifts referenced to an internal tetramethylsilane standard. 
The molecular weight of the monomers was determined by electrospray ionization-mass 
spectroscopy (ESI-MS, Thermo Finnigan LCQ Duo). The number average molecular 
weight (Mn), weight average molecular weight (Mw), and the molecular weight distribution 
of the polymers were determined using gel permeation chromatography using a Waters 
2695 GPC apparatus with a guard and 2 columns. Samples were dissolved in HPLC grade 
dimethylformamide (DMF) at a 2 mg/mL concentration, filtered through a 0.2 μm syringe 
filter, and run at 25 °C using HPLC grade DMF with 0.1% trifluoroacetic acid (TFA) as 
the eluent. Molecular weights were calculated relative to polystyrene standards (Mw = 7.2-














4.2.3 Thermal Properties 
Thermal properties including the glass transition temperature (Tg) and melting point (Tm) 
were determined by differential scanning calorimetry (DSC) from the second heating scan 
at a 10 ˚C/min heating rate using a Mettler Toledo DSC821. The thermal degradation of 
the polymers was studied by thermogravimetric analysis (TGA, Mettler Toledo). The 
temperature at which mass loss began in the thermogram was considered as the thermal 
degradation temperature (Td).  
4.2.4 Compression Molding  
Polymer films were fabricated using a Carver press (Carver 2625) at Tg+50 ˚C or Tm + 
10 ˚C. Briefly, 0.3 g of polymer powder was placed between two Kapton films in a 
preheated steel mold, placed in the Carver press, and compressed using 1000 psi. The 
thickness of the films was adjusted by using spacer shims.  
4.2.5 Melt Rheology 
Melt rheology (Kinexus Ultra+, Malvern Instruments) was used to study solid to melt 
transition behaviour and temperature dependent melt viscosity of the polymers. 
Compression molded polymer films (500 μm in thickness) were tested using a 20 mm 
diameter plate at a constant frequency (1 Hz) with increasing temperature (1 ˚C/min) up to 
200 ˚C. Storage modulus (G'), loss modulus (G"), and melt viscosity were recorded with 
increasing temperature. The solid to melt transition temperature was defined as the 
temperature where G'=G". 
4.2.6 Mechanical Properties 
Mechanical properties of the polymer films were tested using a mechanical tensile tester 
(MTS Sintech/5D Universal Testing Machine) with a 10 N load cell and a 10 mm/min 
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displacement rate. The tensile (Young’s) modulus was calculated from the slope of the 
tangent drawn at the linear portion of the stress strain curve (0 to 2%). Five samples of each 
polymer were tested.  
4.2.7 Hydrolytic Degradation 
Hydrolytic degradation was studied by incubating scaffolds (5 mm diameter discs) in  
1 mL Dulbecco's phosphate-buffered saline (DPBS) with 0.01% sodium azide at 37 ˚C. 
The solution was changed weekly for the duration of the study. At each time point, three 
scaffolds were separated, washed with DI water, lyophilized, and characterized 
gravimetrically for loss in mass and by GPC for Mn and Mw. 
4.2.8 Functionalizability 
The reactivity of the polymers with glutamic acid derivatives was characterized in bulk 
(using polymer solutions) and/or on the surface (using compression molded films). 
1H,1H,2H,2H-perfluorodecanethiol was used to investigate reactivity in the bulk and on 
the surface for HP5GH and in bulk for HP5GP. Surface reactivity for HP5GH and HP5GP 
was also investigated using bovine serum albumin (BSA) and az-Heparin, respectively. 
Az-Heparin was synthesized by reacting heparin with imidazole sulfonyl azide (azo 
transfer reagent) as described in the Appendix C [287]. Characterization was done by X-
ray photoelectron spectroscopy (XPS) for surface and 19F NMR for bulk. A quartz crystal 
microbalance (Q-sense) was used to monitor the conjugation reaction of az-Heparin and 
physical adsorption of BMP-2 on polymer films in real time and the change in frequency 




4.2.9 3D Printing of Scaffolds  
A 3D Bioplotter® Starter Series (EnvisionTEC GmbH, Germany) was used to print the 
scaffolds. The 3D digital model for the scaffolds was designed and saved as an STL file 
using Autodesk® Fusion 360™. The scaffold was designed as a solid cylinder (1 mm in 
height and 9 mm in diameter) to fit in a 48-well plate. Perfactory RP software was used to 
slice the STL file with 250 μm layer height. The sliced file was transferred to 3D 
Bioplotter® and a linear infill pattern with 0.75 mm spacing was created with alternating 
0° and 90° rotation between layers. To begin printing, polymer powder was loaded into a 
stainless-steel syringe and heated to a printing temperature determined by the thermal 
properties of each polymer. Line tests were performed to determine the optimum printing 
parameters, including temperature, pressure, and speed. Briefly, a built-in line test protocol 
was used to print individual struts using a range of print pressures and speeds at a 
predefined print temperature. Print parameters were optimized to print struts with a  
350 μm diameter. Scaffolds were characterized by scanning electron microscopy (SEM, 
Jeol). 
4.2.10 Preparation of Scaffolds for Cell Culture  
To investigate stem cell attachment and proliferation, two sets of scaffolds were printed 
from PLA, HP, HP5BG, HP5GP, and HP5GH. Scaffolds were sterilized by immersion in 
75% ethanol for 30 min, followed by irradiation with a germicidal UV lamp for 1 h per 
side. After sterilization, one set was incubated with fibronectin from bovine plasma (20 
μg/mL, Sigma), while the other set was incubated in Dulbecco's phosphate-buffered saline 
(DPBS). After the incubation solutions were aspirated, the scaffolds were rinsed with 
DPBS three times and transferred into non-treated 48-well plates and maintained in 0.5 mL 
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of growth media per well for 2 h prior to cell seeding.  
For differentiation studies, four groups of HP5GP scaffolds were used. Two of the 
groups were functionalized with az-Heparin (HP5GP-Heparin) by incubating the scaffolds 
in 200 μL az-Heparin solution (0.15 μg/mL az-Heparin in DI water) with  
10 μL of copper sulfate pentahydrate (45 mg/mL) and 10 μL of sodium ascorbate  
(112.5 mg/mL) for 24 h. The scaffolds were washed with DPBS 3 times. One of these 
sample groups was further functionalized with BMP-2 (HP5GP-Heparin-BMP2) by 
incubating the scaffolds in 200 μL BMP-2 solution (7.5 μg/mL) for 1 h. One of the HP5GP 
groups was directly incubated with BMP-2 (7.5 μg/mL) for 1 h, washed with DPBS (3X), 
and used as a control. All scaffold groups (HP5GP, HP5GP-Heparin, HP5GP-Heparin-
BMP2, and HP5GP-BMP2) were transferred into growth media 2 h prior to cell seeding. 
4.2.11 Cell Culture and Characterization  
Human mesenchymal stem cells (hMSCs, Lonza) were cultured in growth media (MEM-
α (minimum essential medium) supplemented with 10% fetal bovine serum (FBS, Gibco) 
and 1% penicillin streptomycin). hMSCs (115,000 cells/mL, passage 3) were seeded from 
the top surface (300 μL per scaffold corresponding to 12,500 cells/cm2) and incubated at 
37 ˚C for 60 min to allow for cell attachment. Scaffolds were gently turned upside down 
and hMSCs were seeded again (300 μL at 115,000 cells/mL) from the top. For cell 
attachment and proliferation studies, the cells were cultured for 14 days in growth media. 
For differentiation studies, after 2 days of culture in growth media, the media was replaced 
with osteogenic induction media (Lonza) and the cells were cultured up to 21 days. Media 
was refreshed every 3 days. For control studies with soluble BMP-2, 1 μL of BMP-2 
solution (165 μg/mL in DI water) was added into the media with each media change. 
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An alamarBlue cell viability assay (Invitrogen) was used to investigate cell viability 
at 2, 4, 7 and 10 days of culture for each group (6 samples per group). To quantify double 
stranded DNA (dsDNA), Quant-iT™ PicoGreen™ dsDNA assay kit (Invitrogen) was used. 
For this purpose, 3 samples per group were collected at culture Day 1, 4, 7, 10, and 14. The 
cells from each sample group were lysed and stored at -80 ˚C until all time points were 
collected for quantification. For both assays, an Infinite M200 Pro (Tecan) plate reader was 
used.  
To visualize cells on the scaffolds, cells were washed with DPBS, fixed in 4% 
formalin for 15 min, and incubated in Triton X-100 solution (0.25% Triton X-100 in DPBS) 
for 15 min to permeabilize the cell membrane. Cells were stained for F-actin using Alexa 
Fluor™ 488 Phalloidin (1:40 in DPBS, Molecular Probes) and nuclei by 4', 6-diamidino-
2-phenylindole (1:2000 in DPBS, DAPI, Invitrogen). For differentiation studies, cells were 
stained for alkaline phosphatase (ALP) with Fast Blue RR/naphthol solution (Sigma), for 
calcium deposition with alizarin red (AR) or immunostained for osteocalcin (OC). For 
fluorometric quantification of AR staining, cells were de-stained using 10% 
cetylpyridinium chloride in 10 mL sodium phosphate (10 mM, pH 7). For immunostaining, 
cells were rinsed with DPBS (3X) and incubated in blocking solution (10% goat serum in 
DPBS) for 30 min after the permeabilization step. Samples were incubated with the OC 
primary antibody (1:200, monoclonal mouse, Fisher Scientific Co.) in staining solution (3% 
BSA, 0.1% Tween-20, 0.25% Triton-X) overnight at 4 ˚C. After washing with 3% BSA 
solution, cells were incubated in Alexa Fluor 488 rabbit anti-mouse secondary antibody 
(1:100, Fisher Scientific Co.) in a 3% BSA solution. Cells were imaged by confocal 
microscopy (confocal and 2-photon system, Leica). The nuclei of the OC and ALP stained 
76 
 
cells were counted using ImageJ to determine OC and ALP positive cells. 
4.2.12 Statistical Analysis 
The data were analysed using KleidaGraph. Data are presented as mean ± standard 
deviation. ANOVA with Tukey’s HSD post hoc test of means was used to make 
comparisons between sample groups. (n≥ 3 samples per group). 
 
4.3 Results and Discussion 
4.3.1 Monomer and Polymer Synthesis 
The HTy monomer was synthesized via Fischer esterification from Tyrosol and 2-(4-
hydroxyphenyl)acetic acid. HTy degrades hydrolytically to form Tyrosol and 2-(4-
hydroxyphenyl)acetic acid (Figure 4.1). Since HTy contains phenyl rings, polymers that 
incorporate it tend to show semi-crystalline behaviour due to π-π stacking interactions. To 
enhance the π-π stacking interactions of HTy-containing polymers and hence their 
processability, p-phenylenediacetic acid (PDA) was introduced into the polymer design. 
Functionalizability was achieved by incorporating amide derivatives of glutamic acid (GR), 
which were synthesized by reacting the dimethyl ester of glutamic acid with alkene or 
alkyne carboxylic acids (Figure 4.1). Alkene or alkyne functionality was chosen to enable 
click-chemistry for tethering bioactive cues. Poly(HTy-50%PDA) (HP), poly(HTy-
45%PDA-co-HTy-5%Gluhexenamide) (HP5GH), poly(HTy-45%PDA-co-HTy-
5%Glupentynamide) (HP5GP), and poly(HTy-45%PDA-co-HTy-5%BocGlu) (HP5BG) 
were successfully synthesized by condensation polymerization of selected combinations of 
HTy, PDA, and GR using DIC and DPTS as a catalyst (Figure 4.1). Note that HTy 
undergoes 1:1 step growth reaction with PDA and GR during polymerization. Thus, the 
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general formula for the functionalizable polymers is poly(HTy(0.5-x)-PDA(0.5-x)-co-HTyx-
GRx). Although we synthesized three polymer compositions with x = 0.01, 0.05, and 0.10, 
x=0.05 was used in this study due to favourable thermal properties, which will be discussed 
below. For simplicity, functionalizable polymers are referred to using the following format: 
HP5GR, where H, P, and GR denote HTy, PDA, and GR, and the number (5) indicates the 
mole percentage of functionalizable GR group. The Mw and PDI of each polymer are given 
in Table 4.1. NMR results are given in Appendix C Figure C.1. 
 
Table 4.1 Properties of the Polymers 
aFrom DMF GPC, relative to PS standards. bFrom DSC measurements. cFrom TGA. dFrom 
tensile tests using compression molded films. eFrom melt rheology using compression 
molded films (η measured at 180 ˚C). fFrom hydrolytic degradation tests (8-week point) 
using DMF GPC 
 
4.3.2 Thermal and Mechanical Characterization 
Thermal properties of the polymers are summarized in Table 4.1. For poly(HTy carbonate) 
(p(HTy)), the Tg was observed at 54 ˚C. A shallow melting peak observed at 130 ˚C during 
the first heating cycle disappeared in the second heating cycle, thus indicating an 
amorphous behaviour. The lack of crystalline behaviour could be due to the rigidity of the 





















p(HTy) 181 1.8 54 - - 350 2.4(±0.3) 38(±7) 5x106 1.1 - 
HP 143 1.7 50 131 147 320 2.1(±0.3) 28(±3) 5x105 3.5 88 
HP5BG 141 1.7 46 125 141 330 1.9(±0.1) 40(±3) 3.3x102 4.0 70 
HP5GH 126 1.6 47 128 143 320 2.2(±0.1) 34(±6) 1.8x103 4.0 18 
HP5GP 129 1.6 50 127 144 320 2.3(±0.1) 38(±2) 2.4x103 4.0 18 
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units from aligning for π-π stacking interactions. When PDA was incorporated into the 
polymer design to form HP, the Tg dropped slightly to 50 ˚C and two distinct melting 
transitions were observed at Tm1 = 131 ˚C and at Tm2 = 147 ˚C (Figure 4.3). Replacing the 
carbonate bonds with PDA increases backbone flexibility and the appearance of two 
melting points may indicate the presence of distinct crystalline regions formed by either 
HTy or PDA π-π stacking interactions. HP5BG, HP5GH, and HP5GP all have similar 
thermal properties to HP with Tg, Tm1, and Tm2 values within 4-6 ˚C (Figure 4.3). All of the 
polymers decomposed at temperatures between 320-350 ̊ C. Note that polymers containing 
5 mole % GR were used in this study as the resulting polymer becomes amorphous for 10 
mole% GR. The average tensile Young’s modulus values of the polymers were in the range 
of 1.9 to 2.4 GPa with yield stress values from 28 to 40 MPa (Table 4.1). Both values were 
not statistically different when compared for each polymer. 
 
 
Figure 4.3 DSC thermograms for the polymers.  
  













HP HP5BG HP5GP HP5GH
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4.3.3 Hydrolytic Degradation 
Polyesters undergo hydrolytic degradation due to the ester bonds in their backbone. The 
hydrolytic degradation of compression molded polymer films (HP, HP5BG, HP5GP, and 
HP5GH) was studied at 37 ˚C in DPBS (Figure 4.4). For HP, a steady decrease in Mw was 
observed between weeks 5 and 22, reaching undetectable Mw values after 22 weeks. For 
HP5BG, a generally linear decrease in Mw was observed for the entire 25-week study. The 
Mw decreased much faster for HP5GP and HP5GH, such that only 18% Mw was retained 
after 8 weeks. We believe that this result could be due to less bulky side groups as compared 
to Boc in HP5BG. There are only a few semi-crystalline polymers that show a comparable 
high rate of degradation, such as poly(glycolic acid) (PGA) (degradation rate of 3-4 months) 
[289]. There was no significant mass loss for HP and HP5BG, which could be due to the 
hydrophobic nature of the polymer limiting the solubility of the degraded chains  
(Figure 4.4B). The rate of mass loss for HP5GH and HP5GP was 3% and 2.5% per week, 
respectively. We did not observe any significant change in Young’s modulus values of 
HP5GH and HP5GP up to 4 weeks (Appendix C, Figure C.6). 
 
 
Figure 4.4 Hydrolytic degradation of polymers over 25 weeks at 37 ˚C in DPBS. (A) 
Percent retained molecular weight (% Mw) with time. (B) Percent mass retention with time. 













































4.3.4 Functionalizability  
In this study, three distinct polymers were developed with pendent reactive groups. HP5GH 
and HP5GP have alkene and alkyne pending groups capable of click chemistry. The alkyne 
group can participate in copper catalysed alkyne-azide cycloaddition (CuAAC) reaction, 
utilized extensively in the literature [272, 274-276]. The alkene group can react with 
sulfhydryl containing compounds in the presence of a photoinitiator and UV light or via 
Michael-type addition reaction [290]. HP5BG contains Boc-protected amine groups 
capable of carbodiimide chemistry, which also enables functionalization with a wide range 
of side chain derivatives to further tether bioactive cues.  
The reactivity of the alkene-containing HP5GH was tested by using a small thiol-
containing molecule (1H,1H,2H,2H-perfluorodecanethiol) and a large protein, BSA (66.5 
kDa), containing cysteine residues (Figure 4.5). A highly fluorinated small molecule 
enabled the study of the reactivity of the polymer in solution via 19F NMR and the reactivity 
of the polymer surface (using compression molded films) via XPS. 19F NMR showed that 
approximately 94% of the alkene bonds were converted to thioether bonds after UV 
irradiation in the presence of a photoinitiator, Irgacure 2959 (Appendix C, Table C.1). 
For the surface reaction, XPS data showed that the fluorine peak was only observed in the 
presence of UV light exposure, whereas the peak was missing for HP5GH sans UV 
exposure and for HP (without the pendent alkene group) with UV exposure (Figure 4.5A). 
The effects of thiol concentration, photoinitiator concentration, and UV irradiation time on 
the reaction yield for compression molded films were studied in detail, and the results are 
summarized in Table C.1. QCM studies indicated that 700 ng/cm2 of BSA was chemically 
tethered onto the surface of HP5GH with UV exposure, which was significantly more than 
81 
 
the 100 ng/cm2 of BSA physically adsorbed onto the surface in the absence of UV exposure 
(Figure 4.5B). The reactivity of the alkyne-containing HP5GP was studied via a CuAAC 
reaction using az-Heparin. The reaction was monitored in real-time by QCM. 1 µg/cm2 of 
az-Heparin was found to be conjugated to the surface of the polymer within 1 hour  
(Figure 4.6). Although az-Heparin was found adsorb onto the HP5GP and HP surface 
(polymer without a reactive pendent group) in the absence of the catalyst, the amount of 
adsorbed az-Heparin was significantly lower: 480 ng/cm2 for HP5GP and 100 ng/cm2 for 
HP (Appendix C, Figure C.7). Heparin is known to bind and release growth factors such 
as bone morphogenetic protein-2 (BMP-2). To further investigate the activity of tethered 
heparin, we studied the interaction of it with BMP-2. Approximately 1 µg/cm2 of BMP-2 
was found to bind to the heparinated polymer surface and remained bound after rinsing 
with DPBS for 10 h, indicating a strong association of BMP-2 with heparin. The ionic 






Figure 4.5 (A) XPS spectra for HP5GH (green), HP reacted with 1H,1H,2H,2H-
perfluorodecanethiol under UV light (red), and HP5GH reacted with 1H,1H,2H,2H-
perfluorodecanethiol under UV light (blue). (B) QCM data showing the change in areal 
mass with time for HP5GH covered with BSA solution in the presence (+) or absence (-) 
of UV light. 
 
 
Figure 4.6 QCM data showing the change in frequency with time for HP5GP. Az-Heparin 
was flowed over HP5GP film for 60 min, followed by DPBS for 240 min, then BMP-2 for 





























4.3.5 Rheological Characterization 
The rheological properties of polymers are crucial to determine their printability. For 
extrusion-based printing at elevated temperatures, the polymer melt must flow at the print 
temperature (Tp), thus, the loss modulus (G") must be greater than the storage modulus (G') 
at Tp. In addition, the polymer must have a fast melt to solid phase transformation (within 
minutes) to rapidly melt in the hot nozzle and rapidly solidify when extruded from the 
nozzle [13, 261]. For instance, PLA, the most widely used polymer in 3D printing, shows 
a fast phase transformation, indicated by a sharp drop in G' within a very narrow 
temperature window (Figure 4.7). For commercial PLA, solid to melt transition occurred 
at Tsm = 180 ̊ C and melt viscosity was equal to 8.4×10
5 mPa·s above 180 ̊ C (usual printing 
temperature). For p(HTy), Tsm = 140 ˚C, with a shallow drop in G' and a relatively high 
melt viscosity value (η = 5×106 mPa·s). For HP, η was significantly reduced to 5×105 mPa·s 
with a significant drop in G' during solid-to-melt transition (at Tsm = 150 ˚C) (Figure 4.7), 
which is consistent with the impact of incorporating PDA on the thermal properties. Note 
that the melt rheological behaviour of HP was similar to PLA. Functionalizable polymers 
showed extended transition regions with Tsm = 150 ̊ C, 140 ̊ C, and 138 ̊ C, and η = 3.3×10
2 
mPa·s, 1.8×103 mPa·s, and 2.4×103 mPa·s (measured at 180 ˚C), for HP5BG, HP5GH, and 
HP5GP, respectively (Figure 4.7). This result could be due to hydrogen bonding 
interactions between the amide groups present in the glutamic acid derivatives. The melt 





Figure 4.7 Plots showing the change in storage modulus (G’) and loss modulus (G”) of the 
polymers with temperature (T). Solid to melt transition temperature is defined as the 
temperature where G’=G”. 
 
4.3.6 3D Printing  
An EnvisionTEC 3D Bioplotter®, an extrusion-based printer, was used to print the 
polymers. Initial extrusion tests were performed to determine the lowest print temperature 
(Tp) and polymer incubation time to equilibrate the print temperature (te). Following this 
study, printing parameters including print pressure (P) and print speed (νp) were determined 
by performing line tests using two needle sizes. The summary of printing parameters to 
create 350 μm diameter print lines (struts) is given in Table 4.2. 3D scaffolds printed from 
HP, HP5BG, HP5GP, and HP5GH showed identical resolution when compared with 
scaffolds printed from PLA (Figure 4.8). SEM images showed self-supporting scaffolds 








































































































Table 4.2 Printing Parameters, including Needle Diameter (d), Print Temperature (Tp), 
Time to Equilibrate Temperature (te), Print Pressure (P), and Print Speed (νp) 
Polymer d (mm) Tp (℃) te (h) P (bar) νp (mm/s) 
PLA 0.3 200 0.5 7 2 
HP 0.3 190 1 7 2 
HP5BG 
0.3 170 1 7 2 
0.4 170 1 6 13 
HP5GH 0.3 170 1 7 3 
HP5GP 
0.3 175 0.5 7 1.5 
0.4 175 1 6 4 
 
 
Figure 4.8 Top row: 3D printed scaffolds from PLA, HP, HP5BG, HP5GP, and HP5GH. 
The corresponding SEM images including from top view and cross-section are shown in 
middle and bottom row, respectively. Scale bars are 200 μm for SEM images. 
 
4.3.7 Stem Cell Culture and Osteogenic Differentiation 
hMSCs were cultured on 3D printed scaffolds for up to 14 days. Cells showed gradually 
increasing metabolic activity for the first 10 days, and total cell number (measured by 
dsDNA content) increased gradually starting from days 4 and 7 (Figure 4.9). Confocal 
images of the scaffolds at Day 14 showed that cells had attached and spread uniformly to 




Figure 4.9 (A) Average peak intensities from alamarBlue cell viability assay for hMSCs 
cultured on scaffolds. (B) Average dsDNA quantities found within each scaffold group. 
Error bars represent the standard deviation (n = 6 and 3 samples/group for A and B, 
respectively). (C) Scanning fluorescent confocal 3D reconstructions of F-actin (green) and 
DAPI (blue) stained hMSCs cultured on the scaffolds for 14 days. Scale bars are 200 μm. 
 
To utilize our functionalizable polymeric biomaterial ink platform, we studied the 
effect of heparin-tethered BMP-2 on osteogenic differentiation of hMSCs in osteogenic 
induction media up to 21 days. For this purpose, we printed scaffolds from HP5GP and 
functionalized them with az-Heparin ((+)Hep). One set of the (+)Hep group was then 
tethered with BMP-2 ((+)Hep-BMP2). Unfunctionalized HP5GP was used as a negative 
control. In addition, we included a positive control group where soluble BMP-2 ((+)sBMP2) 
is introduced into the media during media changes. Cells were stained for OC (Figure 
4.10A) and ALP (Figure 4.10B) as markers of osteogenic differentiation. Alizarin Red 
(AR) staining was also used to qualitatively and quantitatively determine calcium 
deposition. When the cells were quantified at day 14, 85±3% and 80±4% of the cells 
stained positive for OC for (+)Hep-BMP2 and (+)sBMP2, respectively, which were 
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day 21, (+)Hep-BMP2 and sBMP2 groups reached 93±4% and 100±5% as compared to 
(+)BMP2 (77±18%), (+)Hep (57±4%), and HP5GP (62±4%). Increased expression of OC 
suggested osteogenic differentiation was upregulated when HP5GP was functionalized 
with Heparin-BMP2 (Figure 4.10C). The (+)Hep-BMP2 group also showed significantly 
higher ALP positive cells (57±3%) as compared to other groups at day 14 (Figure 4.10D). 
When calcium deposition was characterized using AR staining, AR concentration 
increased significantly from ~0.1 to 0.5 mM for 14- and 21-day culture respectively, yet 
the sample groups did not show any significant differences (Figure 4.10E). A longer 




Figure 4.10 (A) Confocal images of hMSCs cultured on 3D printed scaffolds for 14 days 
in osteogenic differentiation media, and immunostained for human osteocalcin (OC) 
(green). Cell nuclei are stained with DAPI (blue). (B) Brightfield images of hMSCs stained 
for alkaline phosphatase (ALP, dark blue/purple) after 14 days of culture in osteogenic 
media. (C) Percentage of cells stained positive for OC corresponding to (A). For Day 14, 
#p<0.2 for Hep-BMP2 as compared to HP5GP and (+)Hep, #p<0.5 for Hep-BMP2 as 
compared to (+)BMP2. For Day 21, p<0.02 sBMP2 group as compared to HP5GP, (+)Hep, 
and (+)BMP2, and *p<0.4 for (+)Hep-BMP2 as compared to HP5GP and (+)Hep. (D) 
Percentage of cells stained positive for ALP corresponding to (B). *p<0.001 for (+)Hep-
BMP2 as compared to other sample groups (n=3). (E) Alizarin Red (AR) staining 
quantification results using fluorometric analysis depicting AR concentration (mM) for 
each scaffold after 14 and 21 days of culture in osteogenic induction media. 
 
4.4 Conclusions 
We used a bottom-up synthetic design approach to develop novel 3D printable polymeric 
biomaterials for extrusion-based printing from biodegradable stiff polymers with tunable 
functionalizability. The polymer designs were based on the hydrolytically degradable 
monomer HTy, which is synthesized from two naturally occurring olive oil components 
(Tyrosol and 2-(4-hydroxyphenyl)acetic acid). Despite the presence of phenyl rings, p(HTy) 













































































Introducing PDA into the synthetic design resulted in the HP copolymer, which showed 
crystalline behaviour due to enhanced π-π stacking interactions. The thermal processing 
properties of HP were almost identical to PLA, the gold standard for extrusion-based 
printing for biomedical applications. Functionalizability was achieved by incorporating 
glutamic acid derivatives (GR) into the synthetic design and generating copolymers of HTy, 
PDA, and GR. Our results showed that 5 mole% of GR addition did not significantly alter 
thermal properties, stiffness, and printability of these polymers. In this study, we 
particularly focused on functionalizable polymers enabling click-based conjugation 
chemistry via alkyne (HP5GP) or alkene (HP5GH) functionality. We successfully 
demonstrated the reactivity of these functional groups in bulk (using polymer solutions) 
and on the surface (using polymer films). 3D scaffolds fabricated from these polymers 
showed uniform strut distribution within the scaffolds, with strut resolution identical to that 
of PLA. When cultured on these scaffolds, hMSCs were highly viable, and uniformly 
attached and spread on the struts. To further demonstrate the utility of the functionalizable 
polymers, we studied the osteogenic differentiation of hMSCs on HP5GP scaffolds 
functionalized with az-Heparin and BMP-2 ((+)Hep-BMP2). Our results showed a 
significantly higher fraction of the hMSCs stained positive for ALP and OC, which are 





3D PRINTING WAVY SCAFFOLDS FOR ENHANCED MSC OSTEOGENESIS 
This chapter has been adapted from the publication: 
S. Ji, M. Guvendiren, 3D Printed Wavy Scaffolds Enhance Mesenchymal Stem Cell 
Osteogenesis, Micromachines (Basel) 11(1) (2019). 
 
5.1 Introduction 
There is a growing interest in developing porous scaffolds for bone tissue engineering 
enabling temporary mechanical support for cells to attach, migrate and produce newly 
formed extracellular matrix to ultimately form a functional bone tissue [291-293]. 
Although bone has a robust regenerative ability, therapeutic interventions are required for 
large bone defects [294, 295]. Grafts (autografts, allografts, and xenografts) are commonly 
used in clinic to fill the defect site and to regenerate bone tissue [296, 297]. Porous scaffolds 
can be considered as an alternative to regenerate bone while mechanically supporting the 
defect site [298]. A wide range of techniques have been developed to fabricate porous bone 
scaffolds, such as gas foaming [299-301], solvent casting and particle/salt leaching [302-
306], phase separation [307, 308], freeze drying [309, 310], and electrospinning [311-313]. 
However, the majority of these techniques fail to precisely control the 3D architecture of 
the scaffolds, including pore size and pore distribution, and also fail to develop 
reproducible scaffolds [291]. 3D printing is an additive manufacturing technique and 
enables fabrication of custom-designed and highly complex 3D scaffolds. 3D printing 
allows the use of patient’s own medical images to design personalized scaffolds that are 
anatomically similar to the defect site. Thus, it has been widely utilized for fabricating 
custom-designed bone scaffolds [82, 145, 314-316]. A wide range of 3D printing 
techniques have been used to fabricate 3D bone scaffolds, such as fused deposition 
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modeling (FDM) [78, 317-319], direct ink writing (DIW) [320, 321], selective laser 
sintering and melting (SLS and SLM) [322], stereolithography (SLA) [323-325], 
continuous digital light processing (cDLP) [326, 327], and inkjet printing [328, 329]. These 
3D printing technologies allow to utilize various printable materials [41] and designs [330]. 
Computational tools have also been utilized to optimize scaffold architecture to achieve 
enhanced permeability and mechanical properties [331-335].  
Mesenchymal stem cells (MSCs) are regarded as a clinically relevant cell source 
for bone tissue engineering due to their ability to proliferate and migrate as well as their 
potential to differentiate into osteogenic lineage (bone) [336-339]. Stem cells are known to 
feel and respond to their microenvironment by regulating their function [174, 340-342]. 
Materials-based approaches have been developed to engineer extracellular matrix (ECM) 
mimetic microenvironments [15, 343, 344], including macro- and nano-scale topographical 
cues to control stem cell behavior [345, 346]. Topographical cues alone have been shown 
to control stem cell response, such as morphology, alignment, proliferation, migration, 
cytoskeletal organization, focal adhesion, nuclear deformation, and differentiation [346-
348]. For example, human MSCs (hMSCs) are shown to produce bone mineral when 
cultured on substrates with the nanoscale disorder [349]. Nano-scale roughness is shown 
to enhance MSC osteogenesis even in the absence of induction media [350, 351]. This 
phenomenon is shown to be due to clustering of absorbed proteins on nano-topography, 
which promotes integrin-mediated focal adhesions enhancing cellular contractility and 
stem cell osteogenesis [350]. Micro-scale patterns confining stem cells within cell-
adhesive regions were used to control stem cell shape or cellular spreading. For instance, 
McBeath et al. showed that hMSCs with spread morphology led to actin-myosin-generated 
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tension and promoted osteogenic differentiation [352]. Increasing cellular contractility, or 
cytoskeletal tension, by changing the shape of the multicellular sheets, Ruiz and Chen were 
able to enhance osteogenic differentiation of hMSCs [353]. Mrksich and co-workers 
showed that stem cells residing on curved surfaces became highly contractile and 
differentiated to osteogenic lineage [354]. Lineage commitment of hMSCs on hydrogel 
wrinkling patterns was determined by the pattern morphology, such that hMSCs on 
lamellar patterns formed spread morphology with a high cell aspect ratio (>4) differentiated 
into osteogenic progenitors [355]. When porous 3D scaffolds are considered, pore 
architecture, surface topography and interconnectivity are shown to control osteogenic 
differentiation of human mesenchymal progenitor cells [356]. Simon and co-workers 
fabricated 2D films and 3D porous scaffolds with different techniques (gas foaming, salt 
leaching, phase separation, electrospinning, 3D printing, and spin coating) to examine the 
seeded hMSCs osteogenesis, which indicated that the scaffolds could be optimized to 
control the cell morphology to direct differentiation [357]. Recently, DIW was used to 
create 3D scaffolds with distinct architectures composed of square (SQR), hexagonal 
(HEX), or octagonal (OCT) patterns [358]. Human MSCs were reported to exhibit higher 
cell aspect ratio and mean cell area on OCT scaffolds as compared to SQR and HEX 
scaffolds, and hence, showed significantly enhanced osteogenic differentiation. Although, 
the effect of curvature is well documented in 2D, it has not yet been studied systematically 
in 3D.      
In this work, we used 3D printing to fabricate wavy poly(caprolactone) (PCL) 
scaffolds to investigate the effect of curvature on hMSC osteogenesis. A sinusoidal 
waveform was used to create wavy scaffolds. The wavelength and amplitude of the 
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sinusoid were systematically varied to design five distinct wavy scaffolds. Orthogonal 
scaffold with straight struts was used as a control. First, we investigated the effects of 
scaffold architecture on stem cell growth, including cell attachment, proliferation, and 
shape (spreading). Then, we studied the osteogenic differentiation of hMSCs on wavy 
scaffolds as compared to commonly used orthogonal architecture. The main hypothesis 
behind this study is that the wavy scaffolds can direct a more elongated and stretched stem 
cell morphology resulting in highly organized cytoskeletal arrangement with high 
contractility. This could lead to an increased osteogenesis, the degree of which can be 
controlled by the degree of the curvature or waviness. 
 
5.2 Materials and Methods 
5.2.1 Scaffold Design 
Autodesk® Fusion 360™ (Autodesk Inc., San Rafael, CA, USA) was used to design the 
3D models. The basic 3D model was designed as a cylinder with a diameter of 15 mm and 
a height of 1 mm. The 3D model (.stl file) was then loaded into Perfactory RP for slicing, 
with a layer height equal to 0.25 mm. The sliced file (.bpl file) was loaded into Visual 
Machine, and the infill patterns were selected. A linear pattern was selected for the 
orthogonal scaffolds (i.e., the control group), and a sinusoidal waveform was selected for 
the wavy scaffolds (Figure 5.1). For wavy scaffolds, the amplitude and the wavelength of 




Figure 5.1 Wavy scaffold design containing four layers (left) and schematic showing the 
strut design for wavy scaffolds (right). 
 
Table 5.1 Design and Printing Parameters for the Scaffolds 
Parameter Orthogonal A0.5W2 A0.5W3 A0.5W4 A0.75W4 A1W4 
Amplitude (mm) - 0.5 0.5 0.5 0.75 1 
Wavelength (mm) - 2 3 4 4 4 
Strut Diameter (μm) 533±9 497±73 490±36 513±30 510±32 460±58 
Strut Spacing 1 (μm) 395±6 277±59 350±53 396±72 308±120 336±103 
Struts Per Layer 16 15 15 15 15 15 
Temperature 2 (℃) 80 80 80 80 80 80 
Print Pressure (bar) 7 7 7 7 7 7 
Print Speed (mm/s) 4 4 6 5 5 5 
E 
3
 (MPa) 12.4±0.3 10.5±0.5 11.5±0.2 9.5±0.2 10.7±0.2 11.3±0.5 
Porosity 4 (%) 56.3±0.7 56.5±1.2 55.9±0.3 61.7±0.9 57.6±0.5 57.2±3.1 





5.2.2 3D Printing of Scaffolds 
3D Bioplotter (EnvisionTEC) was used to print the scaffolds using PCL pellets (MW = 55 
kDa, Polysciences Inc). The print temperature and pressure were set to 80 ℃ and 700 kPa 
(7 bar), whereas the print speed was varied from 4 to 6 mm/s for each design to achieve 
(see Table 5.1 for actual values for each design). 
5.2.3 Characterization of the Scaffolds 
3D printed scaffolds were imaged by using a scanning electron microscope (SEM, JSM-
7900F, JEOL) and a micro-computed tomography scanner (micro-CT, SkyScan 1275, 
Bruker). SEM images were used to measure the strut size and the strut-to-strut distance. 
Micro-CT was used to measure the porosity of the scaffolds. Compression tests were 
performed on 3D printed scaffolds using an Instron model 3343 with a 1000 N load cell 
and a 0.5 mm/min displacement rate. Three samples for each scaffold group were tested.  
5.2.4 Preparation of the Scaffolds for Cell Culture 
Scaffolds were sterilized by immersing them in 75% ethanol for 30 minutes, followed by 
1-hour UV exposure (by a germicidal lamp) for each side of the scaffold. Scaffolds were 
then incubated in 20 μg/mL fibronectin solution in 300 μL (bovine fibronectin plasma, 
Invitrogen) overnight to enhance cell attachment. Fibronectin solution was removed, and 
scaffolds were washed with Dulbecco's Phosphate-Buffered Saline (DPBS, Gibco), moved 
into a new well, and kept in growth media prior to cell seeding. 
5.2.5 Cell Culture and Reagents 
Human mesenchymal stem cells (hMSCs, passage 4, Lonza) were cultured in growth media 
(α-MEM (minimum essential medium) supplemented with 10% fetal bovine serum (FBS, 
Gibco) and 1% penicillin-streptomycin (pen-strep, Gibco). Prior to seeding, each scaffold 
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was removed from growth media and placed in a single well in a non-treated 24-well plate. 
The hMSC suspension (133,000 cells/mL) were seeded from the top of the scaffolds  
(300 μL per scaffold, corresponding to approximately 5,000 cells/cm2). Cells were 
incubated at 37 °C for 60 min to allow cell attachment. Scaffolds were then flipped, and 
the same amount of cell suspension was seeded from the top, followed by 60 min 
incubation at 37 °C. The scaffolds were then transferred to a new non-treated 24-well plate, 
and 1 mL of fresh growth media was added to each well. The scaffolds were incubated for 
7 days in growth media. For osteogenic differentiation studies, growth media was replaced 
with osteogenic induction media (hMSC osteogenic differentiation medium BulletKitTM, 
Lonza) at Day 7, and cells were cultured for an additional 14 days. The media was refreshed 
every 3 days in cell culture studies. 
5.2.6 Cell Culture and Characterization 
For stem cell growth studies, alamarBlue assay (alamarBlue™ Cell Viability Reagent, 
Invitrogen) and PicoGreen assay (Quant-iT™ PicoGreen™ dsDNA Assay Kit, Invitrogen) 
was used to evaluate the cell proliferation at day 1, 4, and 7, according to manufacturer’s 
protocol. Tecan plate reader (Infinite M200 Pro, Tecan) was used to complete the assays 
for these studies. To visualize the attached cells on the scaffolds, cells were washed with 
DPBS (3X), fixed with 4% formaldehyde for 15 min followed by DPBS wash (3X), and 
permeabilization in 0.25% Triton-X DPBS solution for 1 hour. Cells were stained for  
F-actin using rhodamine phalloidin (1:40 in DPBS, Invitrogen). Cell nuclei were stained 
with 4′,6-diamidino-2-phenylindole (DAPI, 1: 2000 in DPBS, Sigma). At day 7, cells were 
immunostained for vinculin using anti-vinculin−FITC antibody (1:50, mouse monoclonal, 
Sigma). For this purpose, cells were incubated in 10% goat serum (in DPBS) for 30 min, 
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washed with staining solution (3X, 3% bovine serum albumin + 0.1% Tween-20 + 0.25% 
Triton-X), and incubated in vinculin antibody in staining solution overnight at 4 °C. Cells 
were imaged by using a confocal and multiphoton microscopy (TCS SP8 MP, Leica). 
For differentiation studies, calcium deposition was evaluated AT DAY 21 by using 
alizarin red staining kit (AR, Sigma). After the staining was completed, cells were washed 
with DPBS (3X), and incubated in 10% cetylpyridinium chloride (Sigma) in sodium 
phosphate buffer (10 mM, pH 7, Sigma) to remove the stain. This solution was then used 
to quantify calcium content by using a Tecan plate reader (scanned at 405 nm). Alkaline 
phosphatase activity was studied with QuantiChromTM Alkaline Phosphatase Assay Kit 
(ALP assay Kit, BioAssay Systems). Cells cultured within the scaffolds were first lysed 
with 0.2% Triton-X followed by 3 freeze-thaw circles. The lysate was then reacted with p-
Nitrophenyl phosphate working solution and scanned at 405 nm using a plate reader 
(Infinite M200 Pro, Tecan). For osteocalcin (OC) staining, cells were fixed at Day 14 and 
Day 21. Cells were incubated in 10% goat serum (in DPBS) for 30 min, washed with 
staining solution (3X, 3% bovine serum albumin + 0.1% Tween-20 + 0.25% Triton-X), 
and incubated with the OC primary antibody (1: 200, monoclonal mouse, Invitrogen) in 
the staining solution overnight at 4 °C. After removing the antibody-containing staining 
solution and washing the samples with fresh staining solution, cells were incubated in 
Alexa Fluor 488 rabbit anti-mouse secondary antibody (1: 100, Invitrogen) in staining 
solution for 2 hours. Samples were then stained with phalloidin (rhodamine phalloidin, 
Invitrogen) and DAPI to visualize F-actin and cell nuclei, respectively. Cells were imaged 
by using a confocal and multiphoton microscopy (TCS SP8 MP, Leica). All of the collected 




The data were analyzed using Origin 2016 software. Data were presented as mean ± 
standard deviation. One-way ANOVA with Tukey’s HSD post hoc test of means was used 




5.3.1 3D Printing of PCL Scaffolds 
PCL scaffolds with 6 distinct designs, including one linear design (orthogonal), and 5 wavy 
designs in the form of sinusoidal wave with varying amplitude (A) and wavelength (W) 
(A0.5W2, A0.5W3, A0.5W4, A0.75W4, and A1W4, where numbers denote for the actual 
values of A and W in mm) are printed (Table 5.1). Figure 5.2 shows the pictures, micro-
CT images, and SEM images of the scaffolds. SEM images were used to measure the 
printed strut width and spacing between struts for each design, and results were 
summarized in Table 5.1 Briefly, the average strut width was within the range of  
460 ± 58 to 533 ± 9 μm, and the spacing between struts (strut-to-strut distance) was within 
the range of 277 ± 59 to 395 ± 6 μm.  
5.3.2 Mechanical Tests  
Compression tests were performed on each sample group, and the results are summarized 
in Table 5.1 and Figure 5.3. The compressive modulus (Young’s modulus, E) of all the 
designs were in the range of 9.5-12.4 MPa (Table 5.1). E (9.5 MPa) for the A0.5W4 design 
(with the highest porosity, ~62%) was significantly lower than the rest of the sample groups. 
The orthogonal design (E = 12.4 MPa and porosity = ~56%) showed significantly higher 
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E as compared to A0.5W2 (E = 10.5 MPa and porosity = ~56%), A0.5W4, and A1W4 (E 
= 11.3 MPa and porosity = ~57%). 
 
 
Figure 5.2 Images of the scaffolds. From the top to bottom row, images correspond to 
pictures (top view), micro-computed tomography (micro-CT) images (top view), scanning 
electron microscope (SEM) images, and SEM cross-section images. Scale bars are 500 μm 





Figure 5.3 Young’s modulus (E) values of the scaffolds for each scaffold design. * p < 
0.005 for orthogonal vs. A05W2, A0.5W4, and A1W4; and for A0.5W4 vs. all sample 
groups. 
 
5.3.3 Growth Study  
The hMSC growth studies were performed by culturing cells in growth media for up to 7 
days in growth media. The results for AlamarBlue assay and PicoGreen assay are shown 
in Figure 5.4. The AlamarBlue assay results showed that the measured mean intensities 
increased from Day 1 to Day 7, which indicated an increased metabolic activity with 
culture time. There was an exception for A1W4, which showed a drop from Day 4 to Day 
7. At Day 7, no significant difference was observed between the test groups. For the 
PicoGreen assay, a similar trend was observed as the mean value of  
λ-DNA ascended from Day 1 to Day 7. At Day 7, there was no difference between the test 
groups. The multiphoton confocal images of the stem cells (F-actin in green and cell nuclei 
in blue) cultured on the 3D printed scaffolds for 7 days are given in Figure 5.5. F-actin 
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filaments were aligned with the printed struts that form the substrates, and this alignment 
was more pronounced in the curved regions in wavy scaffolds. 
 
 




Figure 5.5 Multiphoton confocal images of the human mesenchymal stem cells (hMSCs) 
cultured on the scaffolds for seven days. Cells were stained for F-actin (red) and nuclei 
(blue). Scale bars are 200 μm. 
 
5.3.4 Differentiation Study 
Osteogenic differentiation of hMSCs cultured on the 3D printed scaffolds was studied for 
up to 21 days. Figure 5.6 shows the results from AR staining and assay. The scaffolds with 
wavy designs showed more staining (Figure 5.6A) and higher values of mean calcium 
deposition (Figure 5.6B). The value of the mean calcium deposition in wavy groups was 
in the range of 2.5 to 6 times higher than that of the orthogonal group. Specifically, the 
average calcium deposition was equal to 9.33 ± 0.98 mM for A0.75W4, 8.14 ± 2.86 mM 
for A0.5W2, 7.60 ± 1.65 mM for A1W4, 6.12 ± 3.07 mM for A0.5W4, 3.96 ± 2.06 mM 
for A0.5W3, and 1.53 ± 0.10 mM for orthogonal scaffolds, in descending order. ALP 
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activity assay results, at culture Days 14 and 21, are given in Figure 7. Our results showed 
an increase in ALP activity for all sample groups from Day 14 to Day 21, and the ALP 
activity of the wavy scaffolds was higher than that of the orthogonal group at both Day 14 
and Day 21 (Figure 5.7). At Day 14, A0.5W3 (13.16 ± 3.17 a.u.) was significantly higher 
than the orthogonal group (5.96 ± 1.58 a.u.). At Day 21, A0.5W2 (46.83 ± 7.90 a.u.) and 
A0.5W3 (45.51 ± 4.20 a.u.) were much higher than that of the orthogonal group (32.31 ± 
0.89 a.u.). Representative fluorescent images showing vinculin staining at Day 7 are shown 
in Figure 5.8. We observed more pronounced vinculin fibers that were aligned with the 
wavy struts for wavy scaffolds as compared to diffused and randomly oriented vinculin for 
the orthogonal scaffold. Figure 5.9 shows the representative confocal images of the 
hMSCs cultured on 3D printed scaffolds, in which cells were stained for osteocalcin (OC, 
green), F-actin (red), and nuclei (blue) at Culture Day 14 and 21. Osteocalcin staining was 
more pronounced on curved struts as compared to linear struts.  
 
 
Figure 5.6 (A) Optical microscopy images of the hMSCs stained for alizarin red (red) after 
culture in osteogenic induction media for 21 days. Scale are 200 μm. (B) Alizarin red 





Figure 5.7 ALP activity assay results for: (A) Day 14 and (B) Day 21 (* p < 0.15,  
** p < 0.05, for n = 3). 
 
 






Figure 5.9 Multiphoton confocal images for hMSCs that were cultured in osteogenic 
induction media for 14 (top row) and 21 days (bottom row). Cells were immunostained for 




In this study, we used extrusion based DIW printing technology to fabricate PCL scaffolds. 
DIW allowed us to 3D print scaffolds directly from PCL pellets, which were melted within 
and extruded from a steel syringe attached to the print head. PCL was selected as a model 
polymer as it is a “Generally Recognized As Safe” (GRAS) polymer by the U.S. Food and 
Drug Administration and widely used to 3D print tissue engineering scaffolds for both in 
vitro and in vivo studies [82, 322, 359] We used hMSCs as the main cell line due to their 
ability to proliferate, migrate, and differentiate into a wide range of tissue specific 
phenotypes including bone, cartilage, and muscle. Stem cells are known to feel and respond 
to their microenvironment (matrix stiffness, topography, and bioactivity) by regulating 
their behavior [15, 174]]. Here, we focused on the topography, or scaffold architecture. To 
investigate the effects of 3D scaffold architecture on stem cell osteogenesis, we constructed 
scaffolds using struts in sinusoidal waveforms, systematically varying the amplitude and 
the wavelength (Figures 5.1 and 5.2, Table 5.1). The sinusoidal waveform design created 
106 
 
highly curved strut surfaces forming 3D scaffolds with wavy patterns. Our motivation to 
create wavy scaffolds was based on previous studies, which clearly showed the importance 
of substrate curvature on stem cell osteogenesis [353, 354].  
The minimum wavelength and amplitude achievable for a strut size around 500 μm 
were 2 mm and 0.5 mm (A0.5W2). While keeping the amplitude constant at 0.5 mm, the 
wavelength was increased to 3 mm (A0.5W3) and 4 mm (A0.5W4). For the 4 mm 
wavelength, the amplitude was increased to 0.75 mm (A0.75W4) and 1 mm (A1W4). These 
geometrical constraints allowed us to create scaffolds with an average strut-to-strut 
distance of approximately 350 μm (Figure 5.2, Table 5.1). Note that the effect of pore size 
in bone scaffolds has been well studied [305, 314, 360-365], and a minimum pore size of 
~150 μm is usually required for cell migration and tissue ingrowth [247, 293, 366, 367]. 
We then investigated the effect of scaffold design on mechanical properties of the scaffolds 
(Figure 5.3). The compressive modulus (E) values were determined by the design, i.e., 
strut-to-strut contacts between layers, and the overall scaffold porosity. E values were 
significantly the highest for orthogonal scaffolds (12.5 MPa) mainly because these 
scaffolds inherently displayed more strut-to-strut contacts, considering that this design had 
16 struts per layer, whereas all the wavy designs had 15 struts per layer. This design also 
had one of the lowest porosities with ~56%. When wavy scaffolds were compared, A0.5W4 
showed the significantly highest porosity (~62%) corresponding to the significantly lowest 
E value of 9.5 MPa followed by A0.75W4 (58%, 10.7 MPa), A1W4 (57% 11.3MPa), and 
A0.5W3 (56%, 11.5 MPa). A0.5W2 (56%, 10.5 MPa) was an exception and did not follow 
the trend. This was due to reduced strut-to-strut contacts due to the design (Figure 5.2). 
Although the overall scaffold modulus determines the mechanical support level that a 
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scaffold can provide when implanted, it did not affect the stem cell behavior in our study. 
This is because the stem cells feel the mechanics of the individual struts (which was 
uniform for all scaffold groups) that they reside on when seeded on to the scaffolds [358]. 
First, the growth study was conducted to determine the attachment and proliferation 
of the hMSCs cultured on our scaffolds. The metabolic activities of the cells were not 
significantly different from each other at each culture day, but increased significantly with 
culture day, reaching a maximum at Day 7 (Figure 5.4A). The same trend was observed 
when the DNA was quantified (Figure 4B). Note that this trend was not true for the A1W4 
and A0.75W4 sample groups, for which the metabolic activity reached a maximum at Day 
4 and did not change significantly at Day 7. Yet, the DNA count did not show this 
unexpected trend for these two sample groups, which represented the cell proliferation 
more accurately. F-actin staining at Day 7 confirmed that cells attached onto the struts and 
formed confluent layers at Day 7, taking the shape of the struts. Cells on wavy scaffolds 
were highly elongated, especially on the curved edges with well-defined F-actin filaments 
aligned with the scaffold curvature as compared to much bulkier cells on orthogonal 
scaffolds (Figure 5.5). In addition, stem cells on wavy scaffolds showed mature vinculin 
(focal adhesion marker) patches as compared to diffused vinculin staining of cells on 
orthogonal scaffolds at Day 7 (Figure 5.8). Focal adhesion is a vital step in osteogenesis 
[368] in which vinculin directs the interaction between talin and actin to direct the focal 
adhesion process [369]. We investigated if these significant changes in stem cell 
morphology, F-actin expression, and focal adhesion on wavy scaffolds as compare to 
orthogonal scaffolds correlated with stem cell osteogenesis on wavy scaffolds. It was also 
noted that the curvature had a direct effect on cell proliferation, and studies have shown 
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that curvature induced contractility enhances proliferation and cell growth [370-372]. In 
our study, we did not observe a significant difference in proliferation between sample 
groups. This was not contradictory to the literature as each of our wavy scaffolds displayed 
both concave and convex curvature, and the overall cellular behaviour was collective rather 
than distinct for each type of curvature. 
The differentiation studies were conducted after the cells reached a confluent state 
at Day 7, as shown by the growth studies (Figures 4 and 5). At Day 7, the growth media 
was replaced with osteogenic induction media, and cells were cultured for 14 additional 
days in induction media, a total of 21 days in culture. To assess the osteogenic 
differentiation of hMSCs, we quantified calcium deposition and ALP activity and 
performed immunostaining for osteocalcin. The AR assay was used to probe the deposition 
of calcium. Optical microscope images revealed that wavy scaffolds showed more stained 
regions than the orthogonal group. When quantified, all the wavy scaffolds showed higher 
calcium deposition than the orthogonal group, and in particular, two groups (A0.5W2 and 
A0.75W4) showed significantly higher calcium deposition (Figure 5.6). These results 
indicated that the overall contribution of the curvature on these two scaffolds on cellular 
contractility induced calcium deposition was the highest. ALP is a well-known biological 
marker for stem cell osteogenesis [373]. ALP activity increased significantly for all of the 
scaffold groups from Day 14 to Day 21 (Figure 5.7). All the wavy groups showed higher 
ALP activity than the orthogonal group. However, the differences between wavy groups 
and the orthogonal group were not as significant as the results from the AR assay. This 
could be because the ALP expressed at earlier stages of the osteogenesis process. At Day 
14, A0.5W3 showed significantly higher ALP activity (p < 0.05) when compared to the 
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orthogonal group. At Day 21, both A0.5W2 and A0.5W3 were substantially higher than 
the orthogonal group (p < 0.15). To supplement our quantitative differentiation assays, we 
performed OC immunostaining (Figure 5.9) as a marker for osteogenesis. Qualitatively, 
we observed increasing OC staining with culture day, and wavy scaffolds showed more 
OC staining, in particular in the curved regions of the scaffolds. The enhanced osteogenesis 
behaviour on wavy scaffolds could be explained as the effect of the curvature, which led 
to a highly aligned and stretched cellular morphology (Figure 5.5) with mature focal 
adhesions (Figure 5.8), leading to highly contractile cells promoting osteogenesis. We 
strongly believe that our results clearly showed the importance of scaffold architecture on 




In this study, we developed 3D printed PCL scaffolds with wavy or linear patterns to 
investigate the effects of a wavy scaffold architecture on the osteogenic differentiation of 
hMSCs. When cultured in growth media, hMSCs attached and proliferated, forming 
confluent layers on the scaffolds within seven days. We found that hMSCs spread by taking 
the shape of the curved surfaces and exhibited elongated F-actin filaments and mature focal 
adhesion sites (vinculin staining). In contrast, hMSCs were bulkier in shape and showed 
dispersed vinculin staining on the orthogonal scaffold. We found that hMSCs showed 
significantly higher calcium deposition, higher ALP activity, and significantly pronounced 
osteocalcin staining when cultured on wavy scaffolds as compared to orthogonal scaffolds. 
These results are important in that they clearly showed the importance of scaffold 
110 
 
architecture on hMSC osteogenesis and may provide guidance on novel bone scaffold/graft 





SUMMARY, CONCLUSIONS, AND FUTURE WORK 
 
This dissertation introduced the development of a novel bioprinting approach for 
fabricating complex channels within cell-laden hydrogels, a novel bioink platform, and a 
novel UV-stimuli bioink platform, and a polyester-based functionalizable biomaterial ink 
platform for 3D printing of tissue engineering scaffolds. In addition, the effect of the 
scaffold architecture on stem cell differentiation was also investigated. 
 In Chapter 2, the reported approach is a complementary technique to existing 
approaches to fabricate user-defined and tunable channels and does not require rapid solid 
to gel transition of the support material (or shear-thinning behavior), which makes it more 
applicable for a wide range of commercially hydrogel systems. Since our approach does 
not require special chemistries, there are potentially a greater number of commercially 
available options for ink materials. Following this study, the approach could be utilized to 
fabricate microfluidic cell-laden hydrogel chips as in vitro models for drug screening and 
cell behavior studies. 
 In Chapter 3, the reported norbornene-functionalized bioink platforms, cCMC and 
NorCMC, have their advantages in cost-effectiveness, tunability, and cytocompatibility, 
broadening the bioink library of 3D bioprinting. However, the current bioink formulations 
have autogelation issues that limit the printable window, and it is difficult to print the 
bioinks as well-defined structures without support materials. To address these issues, we 
have found that the pH of the formulations can significantly postpone the autogelation point. 
To improve the printability, the in-situ-photocrosslink printing strategy [121] could be 
112 
 
applied to print cCMC and NorCMC. In addition, different crosslinkers are capable of 
adjusting the mechanical and biochemical properties of the bioinks, which indicates a great 
promise of the cCMC and NorCMC in cartilage tissue engineering. 
 In Chapter 4, the reported polyester-based ink platform, including HP5GH, HP5GP, 
and HP5BG, demonstrated great degradability, printability, and cytocompatibility. HP5GP 
and HP5GH were successfully functionalized, and HP5GP was selected to test the function 
of the ink, which was validated via the osteogenic differentiation study. This novel polymer 
platform with tunable functionalizability could be utilized for additive manufacturing of 
biodegradable devices and scaffolds with tailored mechanical and bioactive properties for 
a wide range of medical applications, including bone fixation devices and scaffolds for 
bone regeneration. 
 In Chapter 5, PCL scaffolds with wavy or linear architectures were printed, 
followed by an hMSC osteogenic differentiation study. The results showed hMSCs on 
wavy scaffolds had more calcium deposition, ALP activity, and osteocalcin deposition. 
Although the impact of the scaffold architecture on hMSC differentiation was clear, and 
we had proposed the curvature led to more aligned and stretched cellular morphology, the 
quantification of the impact of the scaffold architectures may be simulated with a proper 
model, which can further optimize the scaffold design for bone tissue engineering. 
 However, the presented studies have their limitations, and warrant future 
investigation. For the bioprinting approach for fabricating complex channels within cell-
laden hydrogels, more characterizations for the HUVEC layer are yet to be performed. 
Permeability of the HUVEC layer is vital to the function of the vasculature. Also, 
immunostaining such as CD31 and VE-cadherin could be performed on the HUVEC layer 
113 
 
to verify cell phenotype and the cell-cell junction. Besides, the HUVEC layer cannot fully 
resemble the actual vessel structures, which have multicellular and hierarchical structures 
instead of a HUVEC monolayer. For the norbornene-modified CMC bioink platforms, one 
significant drawback is the print fidelity. Current ink formulations do not allow printing 
self-supportive cCMC/NorCMC without printing support materials. To address this issue, 
the in-situ crosslink strategy could be utilized as a potential solution [121]. As to the 
polyester-based ink platform with tunable properties, although the bioactivity was tunable, 
we did not directly evaluate the bioactivity. Due to our limited access to animal models, in 
vivo tests could have been performed to demonstrate the potency of the developed 
biomaterial ink. Moreover, thermal degradation should be considered and characterized, 
and the mechanical properties of the scaffolds could be tracked during the culture process. 
In the final chapter, to study the impact of scaffold architecture on hMSC osteogenesis, we 
performed multiple characterizations for osteogenesis. However, most of these were to 
probe the overall osteogenic expression of the cells on the scaffolds. This might be the 
reason for not to observe any significant difference between the different wavy scaffolds. 
More tests at a single cell level could potentially provide more detailed information to 
identify the optimal wavy pattern to enhance hMSC osteogenesis.  In addition, the strut 
size (or the size of the wavy patterns) utilized in this study was much larger than that of a 
single cell due to limitations in 3D printing technology, which inherently limits our ability 





SUPPLEMENTARY DATA OF CHAPTER 2 
 
This appendix includes NMR data and line test data of Pluronic F-127 
 
Figure A.1 1H NMR spectrum of methacrylated hyaluronic acid (MeHA) and 
methacrylated alginate (MeAlg). For MeHA, the functionalization was of ~90%, 
determined from the integration of the vinyl group (δ=5.8, 1 H and δ=6.25, 1 H) with 
respect to the HA backbone (δ=3.20-4.20, 10 H). For MeAlg, the functionalization was of 
~72%, determined from integration of vinyl group (δ=5.8, 1H, and δ=6.25, 0.72 H) with 












Figure A.2 Line test results showing the strut width plotted against print speed and print 








SUPPLEMENTARY DATA OF CHAPTER 3 
 
This appendix includes NMR data and rheological data of cCMC and NorCMC under 
UV. 
 
Figure B.1 1H NMR spectra of (A) cCMC and (B) NorCMC. 
 
 
Figure B.2 Time sweep test of ink formulations under light exposure, (A) 10% NorCMC 










SUPPLEMENTARY DATA OF CHAPTER 4 
 
C.1 Monomer Synthesis 
C.1.1 Synthesis of 4-hydroxyphenethyl 2-(4-hydroxyphenyl)acetate (HTy) 
A 2 L round bottom flask was attached to an overhead stirrer and a Dean-Stark apparatus 
with water-cooled condenser and a heating mantle was placed beneath the flask. 4-
hydroxyphenylacetic acid (157.4 g, 1.03 mol), Tyrosol (142.9 g, 1.03 mol), phosphoric 
acid (5.07 g, 51.7 mmol), and 315 mL of toluene were added to the flask. The reaction 
mixture was stirred and heated at reflux until no more water was collected by azeotropic 
distillation. The reaction mixture was allowed to cool and phase separate and the upper 
layer was decanted leaving a thick syrup. The syrup was dissolved in 600 mL of ethyl 
acetate and washed twice with 150 mL of 5% sodium bicarbonate solution and twice with 
150 mL of brine solution. The ethyl acetate solution was dried over magnesium sulfate and 
concentrated in vacuo to obtain a thick syrup. The syrup was concentrated in vacuo several 
times with cold dichloromethane to obtain a white powdered residue. The powder was 
recrystallized from a dichloromethane:hexane mixture, collected by vacuum filtration, and 
dried in a vacuum oven at 40 ˚C for 72 h. Yield: 223 g, 79%.  Melting Point: 94 ˚C. 1H 
NMR (500 MHz, DMSO-d6, δ in ppm): 9.27 (s, 1H), 9.18 (s, 1H), 7.02 - 6.94 (m, 4H), 6.71 
- 6.64 (m, 4H), 4.14 (t, J = 6.9 Hz, 2H), 3.48 (s, 2H), 2.74 (t, J = 6.9 Hz, 2H). 
C.1.2 Synthesis of Dimethyl hex-5-enoylglutamate (Gluhexenamide dimethylester)  
L-glutamic acid dimethyl ester hydrochloride (1.0 g, 4.7 mmol) was mixed with 
triethylamine (0.47 g, 4.7 mmol) in 10 mL of dichloromethane (DCM). Separately, 5-
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hexenoic acid (0.59 g, 5.2 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
hydrochloride (EDCI) (0.99 g, 5.2 mmol), and hydroxybenzotriazole monohydrate (HOBt) 
(0.80 g, 5.2 mmol) were dissolved in 10 mL DCM. The two solutions were combined and 
stirred overnight. The solution was washed twice with 20 mL of 10% sodium bicarbonate 
solution, dried over magnesium sulfate, and concentrated in vacuo to obtain an oil that was 
used without further purification. Yield: 86 %. 1H NMR (500 MHz, DMSO-d6, δ in ppm): 
8.18 (d, J = 7.5 Hz, 1H), 5.77 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.03 - 4.90 (m, 2H), 4.23 
(ddd, J = 9.2, 7.5, 5.3 Hz, 1H), 3.60 (s, 3H), 3.57 (s, 3H), 2.42 - 2.31 (m, 2H), 2.10 (t, J = 
7.6 Hz, 2H), 2.02 - 1.90 (m, 3H), 1.79 (dddd, J = 13.8, 9.2, 7.9, 6.6 Hz, 1H), 1.55 (d, J = 
7.5 Hz, 2H). 
C.1.3 Synthesis of Hex-5-enoylglutamic acid (Gluhexenamide) 
Dimethyl hex-5-enoylglutamate (1.1 g, 4.5 mmol) was combined with sodium hydroxide 
(0.5 g, 12.5 mmol) in a 3.5:1 tetrahydrofuran:water mixture (7 mL). The resulting solution 
was stirred overnight and concentrated in vacuo. The pH was lowered to ~3 by adding 
concentrated hydrochloric acid. This solution was extracted with 3 portions of 20 mL ethyl 
acetate. The ethyl acetate solution was dried over magnesium sulfate and concentrated in 
vacuo. 0.8 g of oily residue was obtained. Yield: 90%. 1H NMR (400 MHz, DMSO-d6, δ 
in ppm): 12.40 (s, 2H), 8.02 (d, J = 7.8 Hz, 1H), 5.77 (ddt, J = 16.9, 10.2, 6.6 Hz, 1H), 5.09 
- 4.85 (m, 2H), 4.17 (ddd, J = 9.2, 7.9, 5.1 Hz, 1H), 2.28 - 2.20 (m, 2H), 2.14 - 2.07 (m, 
2H), 2.03 - 1.87 (m, 3H), 1.79 - 1.66 (m, 1H), 1.61 - 1.49 (m, 2H). ESI-MS m/z: [M-H]-  
Calculated for C11H16NO5
- 242.10, found 242.09. ESI-MS: [M+Na]+: Calculated for 




C.1.4 Synthesis of Dimethyl pent-4-ynoylglutamate (Glupentynamide Dimethylester) 
L-glutamic acid dimethyl ester hydrochloride (1.0 g, 4.7 mmol) was mixed with 
triethylamine (0.47 g, 4.7 mmol) in 10 mL DCM. Separately, 4-pentynoic acid (0.51 g, 5.2 
mmol), EDCI (0.99 g, 5.2 mmol), and HOBt (0.80 g, 5.2 mmol) were dissolved in 10 mL 
DCM. The two solutions were combined and stirred overnight. The solution was washed 
twice with 20 mL of 10% sodium bicarbonate solution, dried over magnesium sulfate, and 
concentrated in vacuo to obtain an oil that was used without further purification. Yield: 
93 %. 1H NMR (400 MHz, DMSO-d6, δ in ppm): 8.32 (d, J = 7.6 Hz, 1H), 4.28 (td, J = 
8.4, 5.4 Hz, 1H), 3.66 - 3.53 (m, 6H), 2.74 (td, J = 2.1, 1.0 Hz, 1H), 2.43 - 2.24 (m, 6H), 
1.98 (dtd, J = 13.3, 7.8, 5.3 Hz, 1H), 1.90 - 1.71 (m, 1H). 
C.1.5 Synthesis of Pent-4-ynoylglutamic Acid (Glupentynamide) 
Dimethyl pent-4-ynoylglutamate (1.1 g, 4.3 mmol) was combined with sodium hydroxide 
(0.5 g, 12.5 mmol) in a 3.5:1 tetrahydrofuran:water mixture (7 mL). The resulting solution 
was stirred overnight and concentrated in vacuo. The pH was lowered to ~3 by adding 
concentrated hydrochloric acid. This solution was extracted with 3 portions of 20 mL ethyl 
acetate. The ethyl acetate solution was dried over magnesium sulfate and concentrated in 
vacuo to obtain 0.64 g of solid powdered product. Yield: 66 %. Melting Point: 97 ˚C. 1H 
NMR (400 MHz, DMSO-d6, δ in ppm): 12.35 (s, 2H), 8.15 (d, J = 7.9 Hz, 1H), 4.20 (ddd, 
J = 9.2, 7.8, 5.0 Hz, 1H), 2.77 – 2.68 (m, 1H), 2.43 – 2.18 (m, 6H), 2.03 – 1.84 (m, 1H), 
1.83 – 1.65 (m, 1H). ESI-MS m/z: [M+Na]+ Calculated for C10H13NNaO5 250.07, found 
250.02; [M+H]+ Calculated for C10H14NO5




C.2 Polymer Synthesis 
C.2.1 General Synthesis of Polyesters 
In a round bottom flask, 1 equivalent of diol (HTy), 0.97 combined equivalents of diacids, 
and 0.33 equivalents of 1,4-dimethylpyridinium p-toluenesulfonate (DPTS) were 
combined with DCM and magnetically stirred for 15 min. The stirring reaction mixture 
was cooled for 30 min in an ice bath and then 2.1 equivalents of N,N ′ -
diisopropylcarbodiimide (DIC) were added. The stirring reaction mixture was kept in an 
ice bath for 1 hour and then allowed to gradually warm to room temperature overnight. 
After 16 hours, the reaction mixture was precipitated by gradually adding isopropanol (5x 
DCM volume) while stirring. The precipitate was collected by vacuum filtration, 
redissolved in DCM, and reprecipitated using isopropanol twice. The final precipitate was 
collected by vacuum filtration and dried in a vacuum oven at 40 ˚C for 48 hours.  The 
precipitate was analyzed by 1H-NMR, FTIR, GPC, DSC, and TGA.  
C.2.2 Synthesis of Poly(HTy-co-50%phenylenediacetate Ester) (HP) 
Yield: 88%. GPC: Mn = 84 kDa, Mw = 143 kDa, PDI = 1.7; DSC: Tg = 50 ˚C, Tm1 = 131 
˚C, Tm2= 147 ˚C; TGA: Td = 320 ˚C; 
1H NMR (500 MHz, DMSO-d6, δ in ppm): 7.35 (s, 
4H), 7.22 - 7.18 (m, 4H), 7.03 – 6.99 (m, 4H), 4.21 (t, J = 6.7 Hz, 2H), 3.92 (d, J = 4.4 Hz, 
4H), 3.62 (s, 2H), 2.84 (t, J = 6.7 Hz, 2H), (Figure S1); FTIR (ATR) νmax (cm
-1): 2917 (w), 
1748 (m), 1728 (m), 1606 (w), 1506 (m), 1468 (w), 1422 (w), 1337 (w), 1218 (m), 1193 




C.2.3 Synthesis of Poly(HTy-co-45%phenylenediacetate-co-5%BocGlu ester) 
(HP5BG) 
Yield: 94%. GPC: Mn = 80 kDa, Mw = 141 kDa, PDI = 1.8; DSC: Tg = 46 ˚C, Tm1 = 125 
˚C, Tm2 = 141 ˚C; TGA: Td = 320 °C; 
1H NMR (500 MHz, DMSO-d6, δ in ppm):  7.60 (s, 
1H), 7.35 (s, 36H), 7.27 - 7.18 (m, 40H), 7.07 – 6.99 (m, 40H), 4.30 (s, 1H), 4.23 (t, J = 
6.6 Hz, 20H), 3.93 (d, J = 4.2 Hz, 36H), 3.64 (s, 20H), 2.86 (t, J = 6.6 Hz, 20H), 2.75 (s, 
2H), 2.28 – 2.19 (m, 1H), 2.13 – 2.04 (m, 1H), 1.39 (s, 9H), (Figure S2); FTIR (ATR) νmax 
(cm-1): 3035 (w), 2956 (w), 1749 (m), 1731 (m), 1607 (w), 1506 (m), 1423 (w), 1339 (w), 
1300 (w), 1218 (m), 1193 (m), 1164 (m), 1120 (s), 1017 (m), 915 (m), 834 (w), 808 (w), 
789 (w), 689 (w), 649 (w). 
C.2.4 Synthesis of Poly(HTy-co-45%phenylenediacetate-co-5%Gluhexenamide Ester) 
(HP5GH) 
Yield: 90%. GPC: Mn = 77 kDa, Mw = 126 kDa, PDI = 1.6; DSC: Tg = 47 ˚C, Tm1 = 128 
˚C, Tm2 = 143 ˚C; TGA: Td = 320 ˚C; 
1H NMR (500 MHz, DMSO-d6, δ in ppm): 8.51 – 
8.47 (m, 1H), 7.34 (s, 36H), 7.25 - 7.16 (m, 40H), 7.05 - 6.98 (m, 40H), 5.82 - 5.69 (m, 
1H), 5.01 - 4.88 (m, 2H), 4.59 - 4.49 (m, 1H), 4.21 (t, J = 6.6 Hz, 20H), 3.92 (d, J = 4.3 
Hz, 36H), 3.62 (s, 20H), 2.84 (t, J = 6.6 Hz, 20H), 2.75 (s, 2H), 2.25 (m, 1H), 2.18 (t, J = 
7.3 Hz, 2H), 2.13 - 2.05 (m, 1H), 2.05 - 1.99 (m, 2H), 1.64 - 1.56 (m, 2H), (Figure S3); 
FTIR (ATR) νmax (cm
-1): 3035 (w), 2955 (w), 1749 (m), 1731 (m), 1674 (w), 1607 (w), 
1506 (m), 1423 (w), 1338 (w), 1300 (w), 1218 (m), 1193 (m), 1164 (m), 1120 (s), 1017 




C.2.5 Synthesis of Poly(HTy-co-45%phenylenediacetate -co-5%Glupentynamide 
Ester) (HP5GP) 
Yield: 84%. GPC: Mn = 78 kDa, Mw = 129 kDa, PDI = 1.6; DSC: Tg = 50 ˚C, Tm1 = 127 
˚C, Tm2 = 144 ˚C; TGA: Td = 320 ˚C; 
1H NMR (500 MHz, DMSO-d6, δ in ppm): 8.62 - 
8.58 (m, 1H), 7.34 (s, 36H), 7.25 - 7.17 (m, 40H), 7.06 - 6.98 (m, 40H), 4.59 - 4.52 (m, 
1H), 4.21 (t, J = 6.7 Hz, 20H), 3.92 (d, J = 4.3 Hz, 36H), 3.62 (s, 20H), 2.84 (t, J = 6.7 Hz, 
20H), 2.80 - 2.70 (m, 3H),  2.41 (s, 4H), 2.30 - 2.22 (m, 1H), 2.13 - 2.04 (m, 1H), (Figure 
S4); FTIR (ATR) νmax (cm
-1): 3035 (w), 2956 (w), 1749 (m), 1731 (m), 1679 (w), 1607 
(w), 1506 (m), 1423 (w), 1379 (w), 1338 (w), 1300 (m), 1218 (m), 1193 (m), 1164 (m), 
1120 (s), 1017 (m), 915 (m), 844 (m), 808 (m), 789 (m), 688 (w), 649 (w), 596 (w), 556 
(w). 
 
C.3 Functionalization Studies 
C.3.1 Bulk Reactivity of HP5GH and HP5GP  
A solution of HP5GH (0.2 g in 2 mL DCM) was combined with 65 mg (3 equivalents) of 
1H,1H,2H,2H-perflurodecanethiol and 10 mg of Irgacure-2959 (photoinitiator). The 
solution was transferred into a quartz cuvette and stirred with a magnetic stirrer. The 
solution was stirred under UV light (365 nm) for 5 hours. The solution was then added 
dropwise into a stirring solution of isopropanol to precipitate the polymer. The resulting 
residue was partially dried and re-dissolved in 2 mL DCM and reprecipitated to wash out 
the unreacted thiol. The resulting residue was filtered and dried in a vacuum oven at 40 ˚C. 




C.3.2 Surface Reactivity of HP5GH with 1H,1H,2H,2H-perflurodecanethiol 
Compression molded films of polymer HP5GH were cut into 5 mm diameter discs. Each 
disc was then kept in a Teflon dish and 10 µL solution of Irgacure-2959 in methanol 
(MeOH) and a 100 µL solution of 1H,1H,2H,2H-perflurodecanethiol in MeOH were added. 
The concentrations of the thiol and Irgacure-2959 are shown in Table C.1. Each film was 
then irradiated with UV for a predetermined time. The film was then flipped and identical 
amounts of Irgacure-2959 and 1H,1H,2H,2H-perflurodecanethiol were added to the other 
side and irradiated with UV. The UV source was kept at a distance of 14 cm and had a 
power of 3.6 mW/cm2.  For longer UV exposures, 50 µL of fresh MeOH was added on top 
to compensate for the loss of solvent due to evaporation. After irradiation of both sides, the 
film was transferred to a 1 dram vial and washed with 1 mL MeOH by vortexing for 20 
seconds. The MeOH was separated and discarded and the washing was repeated 9 more 
time. Finally, each film was sonicated in 1 mL MeOH for 10 min, the MeOH was discarded, 
and the film was dried in a vacuum oven for 16 hours. The treated films were mounted on 
XPS instrument platform and data was collected for two distinct spots. 
C.3.3 Surface Reactivity of HP5GH with Bovine Serum Albumin (BSA) 
Two QCM gold plated crystals were spin coated with 2% (w/v) DCM solution of HP5GH 
and dried overnight under vacuum. A solution of 100 µl BSA (0.25 mg/mL) was placed on 
top of the crystals. To these crystals, a 50 µl solution of Irgacure-2959 (1mg/mL) was 
added (Irgacure-2959 was dissolved by stirring in DPBS for 1 hour).  One crystal was then 
placed under UV light (365 nm) for 5 min and another was kept in dark. Then the crystals 
were rinsed by 10 mL DPBS. The crystals were then placed in the QCM chamber and the 
frequency was measured while a flow of DPBS was maintained. The frequency data was 
125 
 
converted to areal mass using the Sauerbrey equation. 
 
C.4 Surface Reactivity of HP5GP with Az-Heparin 
C.4.1 Synthesis of Az-Heparin 
A batch of 376 mg of Heparin (5 kDa) was combined with 25.9 mg of imidazole sulfonyl 
azide tetrafluoroborate, 30 mg of potassium carbonate, and 7.7 mg of copper sulfate 
pentahydrate and dissolved in 37.5 mL deionized (DI) water. The reaction was stirred 
overnight, then dialyzed for 24 hours using D7884 dialysis membrane from Sigma-Aldrich, 
and lyophilized to obtain a white powdered residue. 
C.4.2 QCM Experiment of HP5GP with Az-Heparin and BMP-2.  
A QCM gold plated crystal was spin coated with 2% (w/v) DCM solution of HP5GP and 
dried overnight under vacuum. The polymer coated crystal was then loaded on QSENSE 
module and flowed over with DPBS until a stable baseline was achieved. Then a solution 
of az-Heparin (1mg/ml) mixed with 0.1 mg copper sulfate pentahydrate and 1 mg of 
sodium ascorbate was flowed over the polymer coated QCM crystal until an equilibrium 
was reached, then DPBS was flowed over the polymer coated surface to remove the 
unreacted az-Heparin. Then a solution of BMP-2 (24 µg/ml) was flowed over the coated 
QCM crystal until an equilibrium was reached. Then DPBS solution was flowed over the 
QCM crystal. 
C.4.3QCM Control Experiment 1: HP5GP/HP + Az-Heparin. A QCM gold plated 
crystal was spin coated with 2% (w/v) DCM solution of HP5GP or 2% (w/v) HP and dried 
overnight under vacuum. The polymer coated crystal was then loaded on QSENSE module 
and flowed over with DI water until a stable baseline was achieved. Then a solution of az-
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Heparin (1mg/ml) mixed with 0.1 mg copper sulfate pentahydrate and 1 mg of sodium 
ascorbate was flowed over the polymer coated QCM crystal for 6 hours. Then a solution 
of sodium dodecyl sulfate (2% aqueous) was flowed for 30 min followed by DI water 
overnight.  
C.4.4 QCM Control Experiment 2: HP5GP + BMP-2. A QCM gold plated crystal was 
spin coated with 2% (w/v) DCM solution of HP5GP and dried overnight under vacuum. 
The polymer coated crystal was then loaded on QSENSE module and flowed over with 
DPBS until a stable baseline was achieved. Then a solution of BMP-2 (24 µg/ml) was 
flowed over the coated QCM crystal until an equilibrium was reached. Then DPBS solution 
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Figure C.2 1H NMR spectra of HP5BG 
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Figure C.6 Left: Young’s modulus over time at 37 ˚C in DPBS; Right: Yield strength over 





Figure C.7 Graph of frequency change over time when az-Heparin, 2% SDS, and 
DPBS were flowed over a QCM crystal coated with HP5GP. 
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